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ABSTRACT 
Myelination of axons is important for proper functioning of the nervous system and 
breakdown of myelin can cause severe disabilities. By regulating nerve conduction, 
myelination is also critical for learning and memory processes. Myelination greatly 
influences conduction properties and remodeling of myelin has been proposed as a 
potential mechanism to adjust and modulated nervous system function. However, to date it 
is still unclear if existing myelin is able to remodel and therefore participate in brain plasticity. 
I used existing zebrafish transgenic lines and generated new constructs to visualize 
myelinated axons in the CNS and to perform in vivo life imaging. Furthermore, I developed 
a single cell ablation method with high spatial and temporal precision to selectively 
demyelinate axon stretches and assess remyelination and remodeling dynamics. Using 
these tools, I was able to describe the growth dynamics of single myelin sheaths and show 
that they are independent of neighboring sheaths and time of initiation. Myelin sheath 
growth can be divided into three different growth phases, an oligodendrocyte intrinsic, highly 
uniformly growth phase that lasts for about 8 hours, followed by a second variable growth 
phase, likely regulated by axon intrinsic mechanisms, in which sheath length differences 
are established. The last growth phase compensates for body growth, and is highly 
predictable by the length increase of the animal.  
By demyelination of short axon stretches I was able to show that myelin segments are able 
to deviate from their otherwise very stereotypic growth dynamics. Ablation of a myelin 
sheath resulted in reinitiation of fast sheath growth in the neighboring sheath to remyelinate 
the gap. A new sheath was formed in the gap and grew which often led to a pushing back 
of the neighboring sheaths that had invaded the demyelinated territory. Thereby, often re-
establishing the pre-ablation pattern, indicating a homeostatic regulation of myelin sheath 
length along an axon. Similarly, partially myelinated axons regularly restored their pre-
ablation pattern after demyelination. Together, these results indicated axonal control of 
myelin sheath length and node of Ranvier positioning to guide the restoration of pre-ablation 
patterns. Furthermore, I observed a high number of asymmetrically grown sheath that could 
v 
 
not be explained by physical barriers like neighboring sheaths or axon collaterals, indicating 
the existence of a molecular growth barrier on the axon. To collect further evidence, I 
investigated the dynamics of the nodal marker Neurofascin and found that it forms clusters 
along unmyelinated axons which are predictive for node of Ranvier positions. In order to 
test if the formation of clusters and the positioning of nodes is axonal activity dependent I 
established an optogenetic setup for long-term stimulation of freely swimming fish. By 
manipulating axonal activity by optogenetics I was able to induce myelin sheath remodeling 
supporting the hypothesis of axonal regulation of node or Ranvier positioning, however, 
similar effects were observed in control animals. 
Together, I was able to describe the dynamics of myelin sheath growth and could show that 
existing myelin segments can remodel and are therefore able to participate in brain 
plasticity. Additionally, I collected evidence that node or Ranvier positioning and therefore 
also myelin sheath length are regulated by axonal mechanisms.  
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1 INTRODUCTION 
 
Our nervous system is probably one of the most complex organs. It has to compute internal 
and external inputs, process them and generate voluntary and involuntary actions. The 
brain, together with the spinal cord, forms the central nervous system (CNS). Besides the 
central nervous system there is also a peripheral nervous system (PNS).  
The CNS consist of two major cell types, neurons and glial cells. The glial cells are 
comprised of microglia, astrocytes, and oligodendrocytes. It was in 1856, that Rudolf 
Virchow introduced the term neuroglia to describe the non-neuronal elements in nervous 
tissue. It was thought that the function of glia is, to keep the nervous system together, hence, 
their name was derived from the ancient greek word gloia, meaning glue (Virchow, 1856). 
Only at the end of the 19th century it became clear that neuroglia consists of several cell 
types. In the following years these cells were described in more detail and Ramón y Cajal 
found that neuroglia contains astrocytes and a ‘third element’. Pio del Rio Hortega stated 
that this third element does not only contain microglia but also another cell type which he 
later called oligodendroglia. He was able to identify the two cell types with the staining tools 
he had developed (Sierra et al., 2016); (Pérez-Cerdá et al., 2015).  
The substance formed by oligodendrocytes was called myelin as initially it was thought to 
come from the axon itself and it was considered to be like marrow of long bones and was 
therefore called myelin (greek: myelos, marrow) (Rosenbluth, 1999). 
  
2 
 
1.1 Structure and function of myelin and subdomains of myelinated 
axons 
 
Architecture of a myelinated axon in the CNS  
The vertebrate central nervous system (CNS) can, macroscopically, be divided in two parts, 
the gray and the white matter. The gray matter contains mainly cell bodies of neurons, while 
the white matter consists of axonal tracts. The white matter appears white, due to the high 
content of myelin lipids. Myelin is a fatty substance formed by oligodendrocytes in the CNS, 
where one cell can myelinate up to 60 axons (Hildebrand et al., 1993). Oligodendrocytes 
and their myelin have important functions in maintaining a functional nervous system. The 
importance of myelin integrity is particularly evident after breakdown of myelin, as this can 
result in axon damage and eventually neuronal cell death (Franklin and Ffrench-Constant, 
2008). 
Oligodendrocytes extend thin processes to form myelin sheaths around axons. Myelin 
sheaths are membranous segments, that wrap around axons multiple times to form a thick 
fatty insulation on the axon (Sherman and Brophy, 2005). The myelin segments are formed 
consecutively along axons, only interrupted by short unmyelinated gaps, the nodes of 
Ranvier. Regions like the soma, dendrites and the axon initial segment (AIS) are spared 
from myelination (Fig 1.1 A). A myelinated axon consists of several domains: the node or 
Ranvier, the paranode, the juxtaparanode and the internode (Bunge et al., 1961).  Each of 
these regions has a specific molecular composition (Peles and Salzer, 2000), suggesting 
different functions (Faivre-Sarrailh and Devaux, 2013). At the myelin sheaths, the 
membrane is wrapped around the axon and tightly compacted, only at the inner and outer 
end of the sheath are cytoplasmic regions, called the inner and outer tongue. The 
extracellular space between the axon and the myelin sheath is called periaxonal space 
(Simons and Nave, 2015) (Fig 1.1 B).  
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Figure 1.1 Architecture of a myelinated axon in the CNS  
(A) Cartoon of a myelinated neuron. Oligodendrocytes (yellow) form myelin sheaths around the axon (blue). 
The sheaths are interspersed with nodes of Ranvier. One oligodendrocyte forms several sheaths. (B) Cartoon 
of a cross-section through a myelinated axon, showing compact myelin and the inner and outer tongue. Between 
the myelin sheath and the axon is the periaxonal space.  
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Architecture of the node of Ranvier  
As briefly mentioned above, a myelinated axon consists of several domains (namely the 
node of Ranvier, the paranode, the juxtaparanode and the internode), with important 
functions in action potential propagation.  
The node of Ranvier is an area highly enriched in specific proteins like voltage-gated sodium 
channels, Neurofascin186 (NF186) and AnkyrinG (AnkG). The node is flanked on both 
sides by the paranodal region. Adjacent to the paranodal region is the juxtaparanode (Peles 
and Salzer, 2000). The node is the region where current can flow and APs are elicited. The 
nodal area is covered by extracellular matrix (ECM) rich material, which is thought to 
participate in node formation and to contribute to the formation of a nodal diffusion barrier. 
Additionally, it is thought to serve as a cationic pool due to the negatively charged sulfated 
proteoglycans (Bekku et al., 2010). The major sodium channel subtype present at the node 
is Nav1.6 (Caldwell et al., 2000). During development Nav1.2 is exchanged by Nav1.6. In 
RGCs, for example, Nav1.2 is expressed when they are unmyelinated and during 
maturation and myelination, Nav1.2 is exchanged by Nav1.6 (Boiko et al., 2001). 
The paranode is the region that is in close contact with the myelin sheath, it is rich in proteins 
like Caspr, Contactin, and glial Neurofascin155 (Peles and Salzer, 2000). Here, the 
paranodal loops anchor the myelin sheath to the axonal surface. Furthermore, it functions 
as a diffusion barrier for nodal proteins. At paranodal junctions, the myelin lamellae form a 
series of cytoplasmic loops, that are close to the axon, the gap is around 2.5-3nm wide, and 
form septate like junctions. The paranodal junctions attach the myelin sheath to the axon 
and thereby separate the nodal part form the internodal axolemma (Rasband and Peles, 
2015). Additionally, paranodal interactions likely regulate the density and distribution of 
nodal components, as KO of the paranodal protein Caspr results in elongated, immature 
nodes in the optic nerve (Rios et al., 2003). 
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The juxtaparanode is the region adjacent to the paranode. It contains mainly voltage-gated 
potassium channels and Caspr2. It is believed to maintain the resting potential and mediate 
communication between the axon and the glial cell (Poliak and Peles, 2003). 
 
 
Figure 1.2 Architecture of the node of Ranvier 
The node of Ranvier contains high densities of sodium channels (Nav) that are linked by AnkyrinG to ß-spectrin. 
Neurofascin 186 (NF186) is as well anchored by AnkyrinG. At the paranode, the paranodal loops anchor the 
myelin sheath to the axon. Here, proteins like, contactin1 (Cntn1) and Caspr are expressed, as well as α-spectrin 
and AnkyrinB. Next to the paranode, at the juxtaparanode high numbers of potassium channels (Kv 1.1/1.2) 
localize. Furthermore, Caspr2, Cntn2, α-spectrin and protein 4.1B can be found at the juxtaparanode. Adapted 
from (Stathopoulos et al., 2015). 
 
Morphologically a lot about myelinated axons and what they are comprised of is known, 
however we have not yet unraveled all mechanisms and functional involvement of 
myelination to nervous system function. 
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Functions of myelin  
Fast saltatory nerve conduction 
The first identified function of myelination is to increase nerve conduction speed. Along an 
unmyelinated axon the conduction speed is directly proportional to the axon diameter. But 
axon diameter cannot increase indefinitely to secure fast action potential conduction in 
larger animals, due to spatial constraints. The evolution of myelin in vertebrates 
circumvented that problem, as with myelination the conduction speed is around 10 times 
faster without increasing the diameter (Zalc et al., 2008) 
The tightly packed myelin is electrically insulating the axon. At the nodes, where it is not 
myelinated, there is a high concentration of voltage-gated sodium channels, and electric 
current can flow. The insulation of myelinated axons increases the resistance of the axonal 
membrane, and as a consequence, the depolarization can spread over a longer distance 
with a lower potential drop compared to an unmyelinated axon (Fig 1.3 A,B). The 
depolarization at the following node is high enough for the voltage gated sodium channels 
to initiate another action potential (AP). The AP ‘jumps’ from one node to the next, hence 
the name saltatory conduction (Fig 1.3 B). At a myelinated axon the speed of AP conduction 
can reach up to 100m/s. There are several factors that influence the conduction speed along 
myelinated axons (Fig 1.3 C). The fiber diameter, for example, is positively correlated with 
conduction speed (Hursh, 1939). The ratio between the axon diameter and the diameter of 
the myelinated fiber, the g-ratio, influences conduction speed as well. Mathematical 
computations show that for a g-ratio around 0.6 the conduction speed is the fastest (RS 
Smith and ZJ Koles, 1970).  
Another factor influencing AP conduction speed, is the myelin sheath length. Here, for a 
fixed diameter, an optimal sheath length can be calculated, where the conduction speed is 
the fastest. Deviations from this optimum result in slower conduction (Brill et al., 1997). The 
same is true for the node length, deviations from the optimal node length result in a slower 
conduction speed (Arancibia-Cárcamo et al., 2017). Furthermore, ion channel density and 
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distribution influence the conduction properties along axons (Freeman et al., 2016). Hence, 
conduction velocity along a myelinated axon can be precisely regulated by adjusting these 
factors (Seidl, 2014).  
 
Metabolic support 
For a long time, it was thought that the only function of myelin is to increase conduction 
velocity. The obvious consequence of myelination is that myelinated axons are shielded, 
except for nodal regions, from access to extracellular substrates. Additionally, axons are 
probably the extreme most example of cellular polarization, where the axon terminal may 
be several centimeters away from the soma, thus creating the need for extensive axonal 
transport of proteins and organelles. Therefore, axons show high energy demand, and 
might require additional sources of energy metabolites (Nave, 2010; Morrison et al., 2013). 
It was shown, that oligodendrocytes provide these metabolites to the axon (Fünfschilling et 
al., 2012; Lee et al., 2012b). Indeed, oligodendrocytes express the monocarboxylate 
transporter 1 (MCT1), a transporter of lactate and pyruvate (Pierre and Pellerin, 2005). 
MCT1 localizes to the myelin sheath, surrounding the axon (Rinholm et al., 2011). 
Oligodendrocyte-specific loss of  MCT1 causes axon degeneration, supporting the 
hypothesis, that trophic support by oligodendrocytes is necessary for axonal survival (Lee 
et al., 2012b). In the current model of oligodenrocytic metabolic support of axons, MCT1 is 
expressed in the inner layers of the myelin sheath, exporting lactate in to the periaxonal 
space. From there, axons take up the lactate via MCT2, convert it to pyruvate and use it for 
ATP production by mitochondria (Fig 1.3 D) (Morrison et al., 2013).  
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Figure 1.3 Functions of myelin and oligodendrocytes 
(A) Schematic of AP conduction along an unmyelinated axon. The AP moves continuously along the axon (B) 
Schematic of AP conduction along a myelinated axon. The depolarization ‘jumps’ from one node to the next, 
resulting in a faster conduction (C) Theoretical dependence of conduction speed. Correlation between AP 
conduction speed and fiber diameter, g-ratio, sheath length, and node length. The fiber diameter and the 
conduction speed have a linear relationship. For the g-ratio, sheath length and node length optimal values can 
be calculated and deviations from that result in slower conduction speed (D) model for metabolic support. 
Lactate is transported from the oligodendrocyte to the periaxonal space from where it is taken up by the axon 
and used for ATP production. Adapted from (Morrison et al., 2013) 
 
In conclusion, myelination is crucial to maintain a healthy nervous system by allowing for 
fast signal transduction and providing metabolic support for the axons.  
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1.2 Formation of myelin and node of Ranvier 
 
Oligodendrocyte precursor cell differentiation  
Oligodendrocytes are generated by differentiation of oligodendrocyte precursor cells (OPC) 
throughout life (Young et al., 2013). During development, OPCs arise in waves in restricted 
areas of the CNS from where they migrate to populate the entire CNS (Sun et al., 1998; 
Miller, 2002; Kessaris et al., 2006). Even in the adult CNS, OPCs account for 5-8 % of all 
cells (Dawson et al., 2000). They are equally distributed and maintain stable densities, due 
to self-repulsive mechanisms (Hughes et al., 2013). OPCs are highly motile cells that extend 
thin processes, with which they scan their environment and they can migrate to areas with 
a demand for myelination (Fig. 1.4 A)(Kirby et al., 2006; Hughes et al., 2013). Upon 
differentiation, OPCs form many nascent sheaths (Fig 1.4 B). A high number of these very 
early nascent sheaths retracts again (Liu et al., 2013), the remaining ones exhibit lateral 
growth (Fig 1.4 C). Once a cell started to differentiate and form myelin sheaths it has, in the 
zebrafish, a time window of 5-6h during which it can form new sheaths. Afterwards no more 
sheaths were added. Sometimes sheaths retracted again, this happened mainly in the first 
days after differentiation, later only few retractions were observed (Czopka et al., 2013).   
 
Fig 1.4 Schematic of OPC differentiation 
(A)  OPC scanning the environment with its processes (B) An OPC, that had just differentiated, forms many 
nascent sheaths on several axons (C) Mature oligodendrocyte. Some of the nascent sheaths retracted some 
were stabilized and grew laterally to increase in length  
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Myelin sheath growth and compaction 
When an OPC starts to differentiate and to form myelin segments, it starts wrapping its 
processes around axons. The outer edge of the myelin sheath is the growth zone, here it 
extends in length (Fig 1.5 A). The inner tongue, the cytoplasmic region at the tip of the 
sheath, wraps around the axon and grows. Simultaneously to wrapping around and 
increasing myelin thickness, the sheath is also growing laterally and extending in length (Fig 
1.5 B). To be able to grow at the inner part of the myelin sheath, newly synthesized 
membrane components have to be transported there. The membrane components are 
transported via cytoplasmic channels, that are maintained as long as the sheath is still 
growing. The majority of these cytoplasmic channels disappears with maturation of the 
sheath. Also at the edge of the myelin sheath, cytoplasmic channels can be found, that are 
in close contact with the ensheathed axon. These cytoplasmic channels later become the 
paranodal loops (Snaidero et al., 2014). Already during growth, myelin sheaths are 
compacted. The compaction of the myelin sheath starts at the outer layers and progresses 
to the inside. MBP is important for the compaction, as it interacts with lipid membranes and 
ensures the adhesion of two lipid bilayers (Harauz et al., 2009). MBP promotes compaction 
by binding to the cytoplasmic leaflet of two opposing myelin bilayers and bringing them 
together. Upon binding to membrane MBP self-association is induced (Bakhti et al., 2014). 
As compaction starts at the outer layer, compaction of the inner layers must be prevented 
until the sheath has reached its length and stopped growing. It has been shown, that MBP 
and CNP have antagonistic functions for the compaction of myelin sheaths. While MBP 
supports compaction, CNP keeps the cytoplasmic channels open by organizing the actin 
cytoskeleton in these channels. Myelin sheaths around large caliber axons often maintain 
cytoplasmic channels, which could be important for the transport of metabolites or to provide 
a route for plasticity of myelin sheaths (Snaidero et al., 2017). 
 
11 
 
 
Figure 1.5 Myelin sheath growth and compaction 
(A) Schematics of unrolled myelin sheaths during myelin sheath growth. The left example shows a very young 
sheath, with only little compaction and many cytoplasmic regions. The middle example shows a more mature 
sheath which has already many compacted parts. The cytoplasmic channels are still open and the sheath is 
growing. The right example shows a mature sheath. Only at the outer edge cytoplasmic regions can be found, 
the rest of the sheath is compacted (B) The myelin sheaths form (A), shown how they wrap around an axon. 
The dotted lines indicate the edges of the sheath underneath the outer layer. The sheaths grow in length as well 
as in thickness. Adapted from (Snaidero et al., 2014) 
 
 
Formation of the node of Ranvier 
Simultaneous to myelin sheath growth node of Ranvier formation takes place. The node 
has a complex morphology and many different proteins need to cluster at the right position. 
It is not entirely clear, how nodes of Ranvier are formed in the CNS and many studies report 
contradictory results, likely due to compensatory mechanisms. However, several intrinsic 
and extrinsic mechanisms that are involved in node formation have been identified.  It is 
hypothesized, that there are three independent mechanisms that govern the formation of 
the node. These mechanisms are thought to be complementary as disruption of one can be 
compensated by the others, but disruption of two results in disrupted node formation. The 
three mechanisms are: (1) clustering of NF186 by the glia derived extracellular matrix, (2) 
the formation of paranodal junctions that act as diffusion barriers and (3) the anchoring of 
sodium channels to the cytoskeleton (Susuki et al., 2013).  
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The cell adhesion molecule NF186 is clustered by interaction with ECM (Susuki et al., 2013) 
and is essential for clustering sodium channels at the node (Ghosh et al., 2018). NF186 is 
anchored to the cytoskeleton by the scaffolding protein AnkG (Salzer, 2003), which is also 
required for clustering of sodium channels, independent of extrinsic mechanisms. In line 
with that, mutations of AnkG or AnkG binding motifs result in disrupted nodes and mis-
localization of nodal components (Rasband and Peles, 2015). Conversely, deletion of ßIV-
spectrin disrupts localization of AnkG and sodium channels (Komada and Soriano, 2002). 
It has also been shown, that sodium channels, AnkG and NF186 can cluster in culture, 
when treated with oligodendrocyte conditioned medium (OCM). Suggesting that a secreted 
factor of oligodendrocytes induces clustering even in the absence of myelin (Kaplan et al., 
1997; Freeman et al., 2015). Similarly, AnkG and sodium channel clusters can also be 
observed in vivo, along unmyelinated axons (Freeman et al., 2015).  
Paranodal interactions represent a form of extrinsic regulators of node formation. Sodium 
channel clustering follows the formation of paranodes, and by longitudinal growth these 
initial clusters are moved along the axon until a neighbor is met to form a node of Ranvier. 
Axo-glia interactions induce the clustering of sodium channels at the node of Ranvier 
(Rasband and Peles, 2015). The localization of Caspr2  depends, as well, on axo-glia 
interactions and the generation of barriers along the axon (Poliak et al., 2001). In contrast, 
developing nodes of Ranvier are defined by AnkyrinG clustering and seem to be 
independent of paranodal axo-glial adhesion (Jenkins and Bennett, 2002) and sodium 
channels can cluster even in the absence of proper paranodal junctions (Ghosh et al., 
2018).  
Furthermore, the actin cytoskeleton is necessary for proper sodium channel clustering. 
Disruption of actin disestablishes the ability of oligodendrocytes to induce sodium channel 
clustering (Kaplan et al., 2001). Similarly, disruption of the cytoskeletal adapter protein 4.1B 
results in disrupted nodes, showing that anchorage to the cytoskeleton is important for node 
formation (Brivio et al., 2017).  
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Together, NF186 clustering by ECM, diffusion barriers formed by paranodal junctions and 
the anchoring of sodium channels to the cytoskeleton form the node of Ranvier and secure 
the right molecular composition of the node (Susuki et al., 2013).   
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1.3 Mechanisms regulating the formation of myelin 
 
Regulation of myelination by OPC differentiation and axon choice  
There are different factors that influence myelination in terms of differentiation of OPCs or 
by regulating the choice of axons to be myelinated. Substantial progress has been made in 
identifying factors involved in CNS myelin regulation, and several oligodendrocyte intrinsic 
and extrinsic factors have been identified (Emery, 2010). However, the exact mechanisms 
by which myelination is regulated remain unknown.  
OPC differentiation: As oligodendrocyte intrinsic factors, certain transcription factors, that 
prevent differentiation, have been identified. Id2, Id4, Hes5 and Sox6 keep OPCs in their 
undifferentiated state and prevent myelin gene expression. Expression of factors that 
prevent myelination led to the depression model of oligodendrocyte differentiation and 
myelination: Only when extracellular signals cause the downregulation of inhibitory factors, 
differentiation and the expression of myelin genes starts (Emery, 2010). Besides these 
transcription factors, it has also been shown, that chromatin remodeling plays a significant 
role. Histone deacetylases (HDACs) regulate oligodendrocyte differentiation and inhibition 
of HDACs delays differentiation and myelination (Shen et al., 2005). HDACs likely promote 
myelination by inhibiting factors that would normally block differentiation (Emery, 2010).  
Axon choice: One extrinsic, physical factor regulating the axon choice for myelination in the 
CNS is the axon diameter, but in contrast to the PNS, where diameter is a fixed threshold 
for myelination, it is less clear in the CNS. In the PNS a diameter of around 1 µm is clear 
threshold for myelination (Snaidero and Simons, 2014). PNS myelination depends on 
Neuregulin1 signaling (Garratt et al., 2000)(Nave and Salzer, 2006) while Nrg1 signaling is 
dispensable for CNS myelination (Brinkmann et al., 2008). Furthermore, in the CNS there 
is a certain overlap of myelinated and unmyelinated fibers between 0.2µm and 0.8µm axon 
diameter (Remahl and Hildebrand, 1982; Snaidero and Simons, 2014). The selection of 
axons to be myelinated seem to involve more complex mechanisms than just axon 
diameter. Accordingly, axons express ligands like Jagged1 (Wang et al., 1998), PSA-NCAM 
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(Charles et al., 2000) or JAM2 (Redmond et al., 2016) which inhibit OPC differentiation or 
myelination. During development PSA-NCAM is expressed on all fibers and then 
downregulated on the axons that are subsequently getting myelinated (Charles et al., 2000). 
Neuronal cell bodies and dendrites express JAM2 to prevent their somatodendritic 
myelination (Redmond et al., 2016).  
Furthermore, neuronal activity is a positive signal for myelination. It is speculated, that 
activity regulates the surface expression of ligands controlling myelination (Itoh et al., 1995) 
or that there is direct signaling from axons to OPCs. OPCs have been shown to have 
glutamatergic synapses and they can respond to axonal activity with depolarization (Bergles 
et al., 2000). 
Indeed, it has been shown that optogenetic or chemogenetic manipulation of activity 
resulted in increased proliferation of OPCs but also increased differentiation into 
oligodendrocytes. Additionally, thicker myelin and de novo myelination were observed 
(Gibson et al., 2014; Mitew et al., 2018; Piscopo et al., 2018). But how activity dependent 
myelination is mediated exactly, is still unknown. 
Recent studies performed in zebrafish helped understanding the role of synaptic vesicle 
release for myelination. Silencing of neurons, by blocking synaptic vesicle release, reduced 
myelination and myelin sheath length along silenced axons. When all neurons were 
silenced, the sheath lengths were again similar to control levels, suggesting that 
oligodendrocytes compare activity along axons and regulate sheath length accordingly 
(Hines et al., 2015). Additionally, oligodendrocytes produced less myelin sheaths, when 
synaptic vesicle release was blocked (Mensch et al., 2015). Furthermore, neuron type 
specific effects of synaptic vesicle release have been reported. In some neurons 
myelination depended on vesicle release while along others myelination was unaffected by 
blocking synaptic vesicle release (Koudelka et al., 2016). However, these studies were all 
done in very young animals and effects of synaptic vesicle release on young sheaths were 
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investigated. Hence, it remains unclear how sheath length at later developmental stages is 
influenced by axonal activity and changes in activity.  
In another study it was observed, that monocular deprivation increased oligodendrogenesis 
and led to changes in myelin sheath length along with slower AP conduction in the optic 
nerve (Etxeberria et al., 2016). However, the shorter sheaths must not be a direct result of 
the monocular deprivation but they could also be a secondary effect by the increased 
oligodendrogenesis, as with more cells and sheaths there is less space for each sheath to 
grow. 
Not only increased activity by manipulations influenced myelination, but also physical 
exercise, like voluntary running, can have positive effects on oligodendrogenesis in the 
spinal cord (Krityakiarana et al., 2010).  
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1.4 Distinct myelination patterns  
 
Not only the amount of myelin, but also myelin sheath length or myelination patterns are 
important for nerve conduction. It remains largely unclear, what regulates sheath length and 
myelination patterns along axons. Axons can display quite unique myelination patterns (Fig 
1.6). One example are the globular bushy cell (GBC) and spherical bushy cell (SBC) axons 
in the gerbil auditory system. Here, myelin sheath length gets progressively shorter closer 
to the synapse. This special arrangement secures precise AP conduction, which is crucial 
for sound localization (Ford et al., 2015). Another special, although very different, 
myelination pattern are the partially myelinated axons of pyramidal neurons in the cortical 
layer II/III. These axons exhibit large unmyelinated gaps between myelin sheaths, that are 
longer than nodes of Ranvier would be. To date, it remains unclear what the function of 
these patterns could be or if they only represent time-points of ongoing myelination 
(Tomassy et al., 2014).  
 
Figure 1.6 Different myelination patterns 
(A) Myelination pattern found in the gerbil auditory system (Ford et al., 2015). Myelin sheaths get progressively 
shorter closer to the synapse (B) Partial myelination pattern found in the cortical layer II/III (Tomassy et al., 
2014). There are large unmyelinated gaps between myelin sheaths.   
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Regulation of myelin sheath length 
There is not much known about the mechanisms controlling myelin sheath length. One 
study, were oligodendrocytes isolated form the cortex and the spinal cord were cultured on 
inert fibers (Lee et al., 2012a), showed that oligodendrocytes from the spinal cord produce 
longer sheaths than cortical oligodendrocytes. Indicating oligodendrocyte intrinsic, region 
specific differences in regulating myelin sheath length (Bechler et al., 2015). Recent 
evidence suggests also influences of axonal activity on myelin sheath length in very early 
stages of sheath growth. Calcium imaging in developing myelin sheaths showed, that high 
frequency calcium (Ca) signals led to sheath retractions, while too low Ca2+ signals halted 
sheath growth. Only medium frequencies of Ca2+ signals resulted in sheath length 
elongation. By blocking neuronal activity it was shown that about half of the observed 
transients are caused by axonal activity (Baraban et al., 2018; Krasnow et al., 2018). 
Together, myelination and node of Ranvier position can have very distinct patterns that 
might have important roles for the proper functioning of these neurons. However, the 
mechanisms regulating how individual axons are myelinated in terms of myelin coverage 
and myelin sheath length remains elusive.   
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1.5 Myelin dynamics 
 
Myelination in the CNS is a dynamic process that takes place at different rates in different 
regions. White matter tracts are myelination rather quickly and to a large amount while grey 
matter is myelinated less. The speed of myelination also varies across different regions 
some are myelinated very quickly while others are myelinated at a slow rate and new myelin 
can be formed lifelong (Miller et al., 2012). Myelination is not a stereotypic process but there 
are different degrees of myelination. It has been shown that certain psychiatric disorders 
come along with changes in white matter. Effects on myelination have also been reported 
in mice raised in social isolation. Mice that were socially isolated during a critical time-period 
during their development displayed hypomyelination of the prefrontal cortex. Reintroducing 
these mice to social contacts could not rescue the phenotype (Makinodan et al., 2012). The 
hypomyelination phenotype could be mimicked by loss of ErbB3 in oligodendrocytes during 
a critical period. In line with that, social isolation reduced the expression of the ErbB3 ligand 
Neuregulin-1 (Nrg1) indicating that the hypomyelination observed after social isolation is 
mediated via ErbB3/Nrg1 signaling. Furthermore, these mice displayed perturbations in 
working memory (Makinodan et al., 2012). Similarly, social isolation of adult mice induced 
myelination changes and led to hypomyelination in the prefrontal cortex (Liu et al., 2012). 
These findings could represent a link to white matter changes that can be observed in 
psychiatric disorders.  
Furthermore, the development of certain tasks coincides with the developmental 
myelination of the according brain regions, as well as differences in white matter correlate 
with the ability in certain tasks, like working memory or musical proficiency (Fields, 2008). 
There is also evidence, that learning a new motor task in humans induces changes in white 
matter. MRI scans of subjects that had learned to juggle showed increases in fractional 
anisotropy (FA), a measure depending on water diffusion and that reflects anatomical 
changes in white matter like axon caliber or myelination (Beaulieu, 2002), compared to the 
control group that did not practice the visuo-motor task. These changes persisted, also after 
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a longer break, in which the task was not practiced (Scholz et al., 2009). Not only learning 
new motor-tasks, but also cognitive training induced white matter changes, measured by 
FA (Takeuchi et al., 2010).  
However, it is not clear from these studies if the reduced myelination is causal for the 
observed behavioral phenotype or if it is just correlative. Furthermore, all of these studies 
reported white matter changes, that were detected by FA, but it remains unclear what these 
increases in FA mean on a cellular level. It could either be, that new OPCs differentiate or 
that already present oligodendrocytes remodel their myelin in terms of length or thickness 
(Zatorre et al., 2012). 
There is increasing evidence that myelination and changes in myelination might have 
functional implications. Studies in mice showed, that the differentiation and localization of 
NG2 glia can be altered by sensory deprivation of voluntary physical exercise (Simon et al., 
2011; Mangin et al., 2012). Furthermore, it was shown, that the proliferation of 
oligodendrocyte precursor cells depends on the activity of neighboring neurons in the 
developing rat optic nerve (Barres and Raff, 1993). To proof a causal relation between 
myelination and behavior McKenzie et al. showed that blocking the formation of new myelin 
resulted in impaired motor-skill learning. Here, deletion of the Myelin Regulatory Factor 
(Myrf), a transcription factor that regulates myelin gene expression (Emery et al., 
2009)(Bujalka et al., 2013), in mice, impairs the formation of new oligodendrocytes and 
myelin, without affecting existing oligodendrocytes. Subsequently, these mice performed 
worse in learning new motor skills like running on a complex wheel (McKenzie et al., 2014). 
In a high temporal resolution study, it was shown that these performance changes occur 
already after 2-3h after introduction to the complex wheel. In line with this, after 2.5h resident 
OPCs started to differentiate , in control mice, resulting in  a decrease in OPC number and 
an increase in oligodendrocytes (Xiao et al., 2016). Together, these studies show that active 
myelination is important for learning new motor tasks.  
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Myelin plasticity to modulate circuit function 
 
The observed white matter changes during learning, and the responsiveness to activity 
make myelination an attractive candidate for how experience can shape the brain. There 
are several potential ways of how myelin can remodel or change circuit function. Activity 
changes could lead to de novo myelination of previously unmyelinated axons or to 
replacement of existing myelin. On the other hand, there could also be changes of already 
existing myelin in terms of length or thickness. To date it is unclear how big the roles of 
these different mechanisms, in activity dependent changes in myelination, are (Kaller et al., 
2017).  
The conduction time along an axon is critical for synaptic plasticity, where timing of AP 
arrival plays a crucial role. Here, precise timing of conduction could be achieved by activity 
dependent feedback mechanisms (Fields, 2015). Changes of myelin, after it has been 
formed, to adaptively change conduction velocity, also after learning, could be an important 
mechanism of neuronal plasticity. Additionally, many functions of our nervous system rely 
on brain oscillations. Here,  conduction velocity plays an important role as well, as already 
small changes in conduction velocity have a huge influences on these oscillations (Pajevic 
et al., 2014). Taken together, myelin remodeling seems to be an ideal candidate to modulate 
circuit function (Fig 1.7). However, direct evidence that existing myelin can remodel is still 
lacking. In this thesis, I am addressing this question to unravel if myelin sheaths can 
plastically remodel and are therefore a candidate to actively modulate circuit function.   
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Figure 1.7 Hypothetical model of how learning can be influenced by myelination. 
(A) Schematic neuronal circuit with two neurons projecting on one. Due to length differences APs will not arrive 
simultaneously. Hence there will be not synaptic strengthening in response to coincident firing (B) After learning 
neuron A could have acquired thicker myelin and therefore faster AP conduction to optimized synchronous 
arrival of AP input from cell A and B. Adapted from (Fields, 2015) 
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1.6 Aim of the thesis 
 
Myelination influences conduction speed, and changes in action potential transmission can 
greatly influence nervous system function. One factor that influences conduction is myelin 
sheath length and the positioning of nodes of Ranvier. Previous studies reported myelin 
plasticity and showed white matter changes upon training or manipulation of activity, 
however, none of these studies provided direct evidence for activity-dependent myelin 
remodeling, rather changes in development were observed. Furthermore, it remains unclear 
how different myelination patterns and node of Ranvier positioning are mechanistically 
established and the dynamics of myelin sheath growth remain to be described. Changes in 
myelination to alter circuit function and modify behavior are an attractive idea, but direct 
evidence of myelin remodeling is still missing. 
In order to address this lack of knowledge I have addressed the following aims during my 
Ph.D. research:  
1. To investigate the dynamics of developmental myelin sheath growth and its potential 
to remodel that underlie the formation of myelinated axons 
2. To investigate the mechanisms that underlie sheath growth dynamics and node of 
Ranvier positioning 
I approached my aims by using zebrafish as a model system and performed in vivo imaging 
in the spinal cord. I took advantage of several existing zebrafish lines and generated new 
lines where neurons, oligodendrocytes or oligodendrocyte precursor cells are labeled. To 
test the ability of myelin sheaths to remodel I established a single cell ablation method with 
which I could precisely remove single myelin sheaths and observe how neighboring sheaths 
reacted. Due to the high similarity between zebrafish and mammalian myelin genes 
zebrafish are a suitable model to study myelination and the optical transparency of the 
zebrafish larvae make them ideally suited for live imaging studies.  
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2 MATERIAL AND METHODS 
2.1 Cloning 
 
All cloning was done in a collaborative effort between Dr. Tim Czopka, Wenke Barkey, 
Tobias Hoche and myself.  
 
pME_memCerulean: To generate the middle entry clone pME_memCerulean the coding 
sequence was PCR amplified from a template plasmid. The primer combination 
attB1_memC/YFP_F and attB2R_memC/YFP_R was used. The PCR product was then 
cloned in to a pDONR221 plasmid with a BP-reaction.  
 
pME_tagCFP: To generate the middle entry clone pME_tagCFP the coding sequence was 
PCR amplified from a template plasmid. The primer combination attB1_tagCFP_F and 
attB2R_tagCFP_R was used. The PCR product was then cloned in to a pDONR221 plasmid 
with a BP-reaction. 
 
pME_KillerRed: To generate the middle entry clone pME_KillerRed the coding sequence 
was PCR amplified from a template plasmid. The primer combination attB1_KillerRed_F 
and attB2R_KillerRed_R was used. The PCR product was then cloned in to a pDONR221 
plasmid with a BP-reaction. 
   
pME_memEYFP: To generate the middle entry clone pME_memEYFP the coding 
sequence was PCR amplified from a template plasmid. The primer combination 
attB1_memC/YFP_F and attB2R_memC/YFP_R was used. The PCR product was then 
cloned in to a pDONR221 plasmid with a BP-reaction. 
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p3E_EYFP-pA: To generate the 3’ entry clone p3E_EYFP-pA the coding sequence was 
PCR amplified from a template plasmid. The primer combination BamHI_C/YFP_F and 
EcoRI_C/YFP_R were used. The PCR product was digested with BamHI and EcoRI and 
was purified using PCR purification kit (Qiagen). The insert was cloned into a pCS2+ 
plasmid using the BamHI/EcoRI restrictions sites. Subsequently the EYFP-pA sequence 
was PCR amplified using the primer combination attB2_C/YFP_F and attB3R_pA_R and 
cloned into pDONR_P2P3R plasmid with a BP-reaction.  
 
p5E_olig1(4.2): To generate the 5’ entry clone p5E_olig1(4.2) a 5.4kb gene regulatory 
sequence upstream of the olig1 gene (Ensembl: ENSDARG00000040948) from genomic 
zebrafish AB wild-type DNA was amplified using the primer combination olig1_F_Sall and 
olig1_R_SacII. The PCR product was digested with KpnI, an endogenous restriction site in 
the olig1 upstream regulatory sequence, and SacII to obtain a 4.2kb insert which was then 
cloned into p5E_MCS.  
 
pME_Nfasca_nostop: To generate the middle entry clone pME_Nfasca_nostop the coding 
sequence of the zebrafish Neurofascin gene (Ensembl: ENSDART00000112655.3) was 
PCR amplified from zebrafish AB wildtype cDNA. The stopcodon was removed from the 3’ 
end using the primer combination attB1_Nfasca_F and attB2R_Nfasca_nostop_R. The 
PCR product was then cloned into a pDONR221 plasmid with a BP reaction.  
 
pTol2_cntn1b:Nfasca-EYFP: The transgenic expression construct pTol2_cntn1b:Nfasca-
EYFP was generated by a multisite LR recombination reaction with p5E_cntn1b  (Czopka 
et al., 2013), the generated plasmids pME_Nfasca-nostop and p3E_EYFP and the Tol2Kit 
plasmid pDestTol2_pA (Kwan et al., 2007). 
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pTol2_huC:tagCFP: The transgenic expression construct pTol2_huC:tagCFP was 
generated by a multisite LR reaction with p5E_huC  (Mensch et al., 2015), the generated 
pME_tagCFP and the Tol2Kit plasmids p3E-pA and pDestTol2_pA (Kwan et al., 2007). 
 
 
pTol2_mbp:memCerulean: The transgenic expression construct 
pTol2_mbp:memCerulean was generated by a multisite LR reaction with p5E_mbp  
(Almeida et al., 2011), the generated entry clone pME_memCerulean and the Tol2Kit 
plasmids p3E-pA and pDestTol2_pA (Kwan et al., 2007). 
 
pTol2_mbp:KillerRed: The transgenic expression construct pTol2_mbp:KillerRed was 
generated by a multisite LR reaction with p5E_mbp  (Almeida et al., 2011), the generated 
entry clone pME_KillerRed and the Tol2Kit plasmids p3E-pA and pDestTol2_pA (Kwan et 
al., 2007). 
 
pTol2_olig1(4.2):memEYFP: The transgenic expression construct 
pTol2_olig1(4.2):memEYFP was generated by a multisite LR reaction with the generated 
plasmids p5E_olig1(4.2) and pME_memEYFP and the Tol2Kit plasmids p3E-pA and 
pDestTol2_pA (Kwan et al., 2007). 
 
 
pTol2_cntn1b:tagCFP: The transgenic expression construct pTol2_cntn1b:tagCFP was 
generated by a multisite LR reaction with p5E_cntn1b  (Czopka et al., 2013), the generated 
plasmid pME_tagCFP and the Tol2Kit plasmids p3E-pA and pDestTol2_pA (Kwan et al., 
2007). 
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pTol2_olig1(4.2):tagCFP-NTR: The transgenic expression construct 
pTol2_olig1(4.2):tagCFP-NTR was generated by a multisite LR recombination reaction with 
the generate plasmids p5E_olig1(4.2) and pME_tagCFP, and p3E_NTR (Karttunen et al., 
2017) and the Tol2Kit plasmid pDestTol2_pA (Kwan et al., 2007). 
 
 
Primers used 
Primer Name Sequence 
attB1_Nfasca_F GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCACCATGTGGACACAGAGGCGGTG 
attB2R_Nfasca_nostop_R GGGGACCACTTTGTACAAGAAAGCTGGGTCTGCCAAAGAGTAGATGGCATTG 
olig1_F_SalI GAAGTCGACGTATGAAGCCTCTTGGCACAG 
olig1_R_SacII ACCGCGGCTGAAAAAAGATATTCAGAGAACATGG 
attB1_memC/YFP_F GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCACCATGCTGTGCTGC 
attB2R_memC/YFP_R GGGGACCACTTTGTACAAGAAAGCTGGGTCTTACTTGTACAGCTCGTCCATGC 
attB1_tagCFP_F GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCACCATGAGCGGGGG 
attB2R_tagCFP_R GGGGACCACTTTGTACAAGAAAGCTGGGTTTAGCGGTACAGCTCGTCCATG 
attB1_KillerRed_F GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCACCATGGGATCCGAGGGCGGCCCCGCC 
attB2R_KillerRed_R GGGGACCACTTTGTACAAGAAAGCTGGGTCTAATCCTCGTCGCTACCGATGG 
BamHI_C/YFP_F GATGGATCCATGGTGAGCAAGGGCGAG 
EcoRI_C/YFP_R GACGAATTCTTACTTGTACAGCTCGTCCATGC 
attB2_C/YFP_F GGGGACAGCTTTCTTGTACAAAGTGGATATGGTGAGCAAGGGCGAG 
attB3R_pA_R GGGGACAACTTTGTATAATAAAGTTGAAAAAACCTCCCACACCTCCC 
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2.2 Animals 
 
All experiments were performed according to local regulations as approved by the local 
regulatory bodies. Zebrafish were kept at 28.5°C with a 14/10-hour light/dark cycle. 
Embryos were kept in 0.3x Danieau's solution at 28.5°C. The transgenic lines used are 
listed in Table 2.1. 
 
Table 2.1 Fish lines used 
Line Reference 
Tg(mbp:EGFP-caax)ue2 (Almeida et al., 2011) 
Tg(mbp:nlsEGFP) (Karttunen et al., 2017) 
Tg(mbp:memCerulean) generated, see also (Auer et al., 2018) 
Tg(mbp:tagRFPt-CAAX) generated, see also (Auer et al., 2018) 
Tg(mbp:KillerRed) generated, see also (Auer et al., 2018) 
Tg(cntn1b:KaltA4) (Mensch, 2015) 
Tg(UAS:GCaMP6s)mpn101 (Thiele et al., 2014) 
Tg(olig1:tagCFP-NTR) generated  
 
Constructs used 
Construct Reference 
UAS:ChR2-mCherry Gift from Baier lab, (Schoonheim et al., 2010) 
 
 
2.3 mRNA synthesis and injections 
 
Transposase plasmid (Tol2Kit) (Kwan et al., 2007) was linearized with NotI (New England 
BioLabs), the digest was subsequently purified with a PCR purification kit (Qiagen) 
according to the protocol. The mRNA synthesis was done with the mMessage machine SP6 
kit (Invitrogen) and then purified with an RNA clean up kit (Qiagen). The concentration was 
measured and the aliquoted transposase mRNA was kept at -80°C until further use.  
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For the microinjections, the injection needle was calibrated to an injection volume of 0.5nl. 
Two injections per egg result in a total injection volume of 1nl. To calibrate the needle, the 
fine tip was broken and test injections into a drop of mineral oil on a stage micrometer were 
done.  
Fertilized eggs were injected at the one cell stage with 1nl of a solution containing plasmid 
DNA at concentrations between 5 and 20ng/µl and transposase mRNA (Kwan et al., 2007) 
at concentrations between 25-60ng/µl and 1% PhenolRed (Sigma Aldrich) for visualization.  
 
Generation of new transgenic zebrafish lines 
To generate stable transgenic lines injected F0 embryos were raised to adulthood and then 
outcrossed with wild-type animals. The embryos were screened for germline transmission 
of the injected transgene under a fluorescent stereo dissecting microscope and raised.  
 
2.4 in vivo live imaging 
 
Confocal imaging 
Fish were either pre-screened at a fluorescent dissecting microscope (Nikon SMZ18) or 
they were screened after embedding at the confocal microscope (Leica TCS SP8). Fish 
were anesthetized with 0.2mg/ml Tricaine in Danieau´s buffer (fish were added in a dish 
containing the solution), after 5min they were transferred in to a vial with 1% ultrapure low 
melting point (LMP) agarose (Invitrogen), subsequently removed and mounted in the 
agarose on a glass coverslip with the head of the fish facing left. If the cell of interest was 
on the other side of the spinal cord fish were mounted with the head facing right. All images 
are oriented that the head faces left. The coverslip with the fish was mounted on a glass 
slide, creating a grease chamber filled with 0.2mg/ml Tricaine in Danieau´s buffer.  
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Images were acquired either as 8- or 12-bit confocal z-stacks with pixel sizes between 47 
and 114nm x/y and a z-spacing of 0.75 - 1µm. 25x 0.95NA and 40x 1.1NA water immersion 
objectives were used. Higher resolutions were used when the images were used for 
subsequent deconvolution. Faster time-lapse imaging was done using a 25x 0.95NA water 
immersion objective with an 8kHz resonant scanner. 
After the fish were imaged, they were released again from the agarose and placed in fresh 
Danieau´s buffer. From 5 days post fertilization (dpf) onwards fish were fed with Sera Micron 
and Paramecia and kept in a 14/10 light/dark cycle.  
 
Spectral Confocal Reflectance Microscopy 
Spectral confocal reflectance microscopy (SCoRe) imaging was used as a method for label 
free visualization of myelin, as myelinated axons reflect more light than unmyelinated axons 
and surrounding tissue (Schain et al., 2014). It was used to verify that partially myelinated 
axons are indeed partially myelinated and that there are no unlabelled oligodendrocytes in 
our lines. The 488nm, 561nm and 633nm laser lines were used and the reflected light was 
detected with a 5nm wide filter centred around the laser wavelength.  
 
Calcium imaging  
For the calcium imaging a light-sheet microscope was used (Leica SP8 DLS). Fish 
expressing GCaMP6s were paralyzed by bath application of Mivacurium chloride and, after 
5min incubation, laterally embedded in a thin u-shaped glass capillary with 1% LMP 
agarose. The light-sheet imaging settings were calibrated for each fish individually and two 
time lapses of each 10min, with a 10min break, were acquired. A 2.5x illumination objective 
was used together with 2.5mm mirrors and a 10x detection objective. 
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2.5 2P Laser cell ablations 
Mbp:KillerRed expressing cells were ablated using an Olympus FV1000/MPE microscope. 
The 2Photon laser used was a MaiTai DeepSee HP (Newport/Spectra Physics) together 
with a 25x 1.05 NA MP (XLPLN25XWMP) water immersion objective. The cells were 
continuously imaged with confocal scans with a 559nm laser to locate and target the 
individual KillerRed labelled cells. A line scan was drawn across the soma and the cell was 
bleached using the MaiTai laser tuned to 770nm (1.75W output) for 500ms.   
 
2.6 Trichostatin A treatment 
Trichostatin A (TSA) was used at a final concentration of 15nM. 1.5µl of the 100µM stock 
solution was diluted in Danieau´s containing 0.2%DMSO. TSA treatment started at 2.5dpf 
for 24-26h.  
 
2.7 Metronidazol treatment 
Metronidazol (MTZ) was used at a final concentration of 10mM. The solution was made 
fresh the same day (Curado et al., 2008). 0.2%DMSO was added to Danieau´s buffer, then 
MTZ was added and the solution was stirred until all MTZ was dissolved. 2.5dpf embryos 
were added for 24-26h.  
 
2.8 Mivacurium chloride treatment 
Mivacurium chloride was used at a final concentration of 0.5mg/mL. Fish were added to the 
solution and incubated for 5 min, they were embedded and subsequently imaged. 
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2.9 Optogenetics 
For testing the optogenetic setup, Channelrhodopsin (ChR2) and GCaMP6s expressing fish 
were embedded in a glass bottom dish and imaged with a confocal microscope. The blue 
LED was mounted into the lid of the dish. Baseline recordings were performed, followed by 
a light stimulation with 0.1 Hz. As the light of the LED was detected in the GCaMP6s channel 
the background signal was measured as well and subtracted from the GCaMP6s signal of 
the Channelrhodopsin expressing cell. Calcium traces were analysed with Fiji and Matlab.  
For stimulation of freely swimming fish the LED was mounted in the lid of a 12 well plate. 
The fish were placed in the well in Danieau´s buffer. During the optogenetic treatment fish 
were kept in the dark at 28.5°C.  
Stimulation protocol: The fish were stimulated for 6h per day on two consecutive days. They 
were stimulated with 4Hz for 15s in 15min intervals.  
 
2.10 Image processing 
 
Images were analysed with Fiji, LasX and Imaris. Deconvolution was done with the Huygens 
Essentials version 16.10 1p2 (Scientific volume imaging, the Netherlands, __http://svi.nl__).  
Fiji was used for registration of the single channels (StackReg) and adjustments of 
brightness. All measurements were done in Fiji. LasX was used to align channels. 
Photoshop CS6 was used to adjust the brightness, and Adobe Illustrator CS6 was used to 
assemble the panels.  
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2.11 Data analysis 
 
Cell counting 
To assess cell numbers, transgenic lines with a fluorescent nuclear tag fused to EGFP were 
used. For the developmental analysis of oligodendrocytes different fish were imaged at 
different ages, for the myelin delay experiments the same fish were imaged at different 
ages. Fish were mounted laterally and the whole depth of the spinal cord was imaged 
around somite 17. Cells were counted in the whole field of view and then normalized to 
100µm length of spinal cord, to obtain the cell density. The transmitted light was imaged as 
well to measure the somite length to calculated the oligodendrocyte number independent 
from fish growth. 
Sheath length measurements 
Myelin sheath length was measured in Fiji using the segmented line tool. Sheath length was 
either measured with membrane tagged fluorescent protein or with nodal marker. In both 
cases it was measured in z-stacks, neglecting the third dimension. For the myelin label 
sheath length was measured from beginning to the end of one myelin sheath, for the node 
distance the length between two consecutive nodes was measured.  
Relative sheath length 
To calculate the relative sheath length, the length at the end of the imaging was normalized 
to one. The values measured at the different days of imaging were divided by the end length.  
Reconstructions 
Imaris was used to reconstruct myelinated axons. With the filament tracer and the magnetic 
lasso, the axon was semi-automatically traced and reconstructed in a 3D projection. The 
same was done for the myelin sheaths.  
Prediction of myelin sheath length 
For the sheaths in the elongation phase (≥4 days post initiation (dpi)) the relative increase 
in sheath length equals the relative increase in somite length.  
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𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑑𝑝𝑖
𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 4 𝑑𝑝𝑖 ൌ  𝑠𝑜𝑚𝑖𝑡𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑑𝑝𝑖𝑠𝑜𝑚𝑖𝑡𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 4 𝑑𝑝𝑖 
After transposing the equation, one can calculate the predicted sheath length at any day 
after 4dpi by knowing the somite lengths at these days.  
 𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑑𝑝𝑖 ൌ  𝑠𝑜𝑚𝑖𝑡𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑑𝑝𝑖𝑠𝑜𝑚𝑖𝑡𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 4 𝑑𝑝𝑖  ൈ  𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 4 𝑑𝑝𝑖 
Correction for body growth 
To correct the sheath length for body growth I divided the sheath length at the given day by 
the relative increase in body growth. The sheath length and somite length at 4dpi was used 
as a reference.  
𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑑𝑝𝑖௖௢௥௥௘௖௧௘ௗ ൌ          𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑑𝑝𝑖     𝑠𝑜𝑚𝑖𝑡𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑑𝑝𝑖
𝑠𝑜𝑚𝑖𝑡𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 4 𝑑𝑝𝑖  
Relative position on the axon:  
To assess the relative positon of myelin sheath along an axon landmarks were used to 
measure a defined distance before and after ablation. Axon collaterals or somata were used 
as such landmarks. The relative position on this defined stretch of axon was calculated by 
using the middle of the respective sheath length. The change in position was then calculated 
by the difference in the sheath positions before ablation and after remyelination. 
For the controls the changes in sheath position during similar time intervals were measured. 
Axon diameter:  
Axon diameter was measured in light microscopic images. Therefore, the area of 3 axon 
stretches, around 20µm long, was measured and divided by the exact length of the stretch. 
The mean of the three values was calculated and used as the axon diameter.  
𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟௔௫௢௡ ൌ  𝑎𝑟𝑒𝑎 ௔௫௢௡ ௦௧௥௘௧௖௛𝑙𝑒𝑛𝑔𝑡ℎ௔௫௢௡ ௦௧௥௘௧௖௛ 
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Growth rate  
The growth rate at any given day is always the length change from the day before to the 
given day. Growth speed at day x was calculated by subtracting the length at day x minus 
the length at day x-1. 
𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑒௫ௗ௣௜ ൌ  𝑙𝑒𝑛𝑔𝑡ℎ௫ௗ௣௜ െ  𝑙𝑒𝑛𝑔𝑡ℎ௫ିଵௗ௣௜ 
Daily growth rate from day x-y was calculated by subtracting the length at day y minus the 
length at day x divided by the number of days 
𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑒௫ି௬ௗ௣௜ ൌ  𝑙𝑒𝑛𝑔𝑡ℎ௬ௗ௣௜ െ  𝑙𝑒𝑛𝑔𝑡ℎ௫ௗ௣௜𝑦 െ 𝑥  
Calcium imaging 
To analyze the Calcium traces, regions of interest (ROIs) were drawn around the somata 
of the neurons and the mean intensity was measured with Fiji. The traces were imported in 
to Matlab and normalized by the first 100 frames. For the Calcium event detection, a 
threshold of 20% above average was used.  
Relative process position  
Sheath length was measured and the distance of the sheath end to the process. The ratio 
of the distance of the left sheath end to the process and the total sheath length was 
calculated. 0.5 was subtracted from that ratio to calculate the distance of the process from 
the center. With negative numbers indicating the process being on the left half of the sheath, 
positive numbers on the right half. The result was multiplied by two, to normalize the scale 
to go from -1 to 1.  
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑝𝑟𝑜𝑐𝑒𝑠𝑠 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 ൌ  ቆ𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒௦௛௘௔௧௛ ௘௡ௗି௣௥௢௖௘௦௦𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ െ 0.5ቇ ∗ 2 
Quantification of ensheathment 
To measure the percentage of the axon ensheathed with myelin the length of the axon in 
the field of view was measured as well as the myelin sheaths on it. The sum of the myelin 
sheath lengths was divided by the axon length.  
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𝑒𝑛𝑠ℎ𝑒𝑎𝑡ℎ𝑚𝑒𝑛𝑡ሾ%ሿ ൌ  ∑𝑚𝑦𝑒𝑙𝑖𝑛 𝑠ℎ𝑒𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ𝑎𝑥𝑜𝑛 𝑙𝑒𝑛𝑔𝑡ℎ ∗ 100%  
 
Fluorescent intensity measurements 
To measure fluorescent intensities along an axon, a segmented line with 15px width was 
drawn along the axon. The values were measured, exported into Excel and normalized by 
the mean fluorescence.  
Correlation of cluster and node 
To correlate the Nfasca-EYFP clusters before myelination with the node position after 
myelination the images were aligned by landmarks, to exclude mistakes due to body growth 
of the fish. Somata of neurons or axon collaterals were used as landmarks. To assess if the 
cluster and the node are at the same position a box, being as wide as the node, was drawn 
around the node and if the cluster overlapped with the box it was counted as being at the 
same position. If the cluster did not overlap with the box it was not counted. 
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2.12 Statistics 
 
Statistical analysis was done using GraphPad prism. All data were tested for normal 
distribution using the Kolmogorov-Smirnov normality test, unless the sample size was 
smaller than 5, in this case the Shapiro-Wilk normality test was used. All data in the running 
text are presented as mean ± SD independent of normality. In the figures, normally 
distributed data are presented as mean ± SD, whereas non-normally distributed data are 
presented as median with the 25% and 75% percentiles. When the data was normally 
distributed, either paired or unpaired t-test (two variables) or ANOVA (three or more 
variables) were performed. If data was not normally distributed, either Wilcoxon matched 
pairs signed rank test or Mann-Whitney test (two variables) or Tukey’s multiple analysis 
(three or more variables) were used. To test for correlation, either the Pearson or Spearman 
coefficient were calculated. P-values <0.05 are denoted with *, <0.01 with ** and p-values 
< 0.001 with ***.  
 
2.13 Solutions and Buffers 
Danieau’s Buffer 
Stock solution 
Reagent Quantity for 900ml 30X stock solution 
NaCl (Roth) 91.52g 
KCl (Roth) 1.41g 
MgSO4 (VWR Chemicals) 2.66g 
Ca(NO3)2 (Roth) 3.83g 
Hepes (Roth) 32.17 
Distilled Water  Ad 900ml 
Adjust pH to 7.6  
0.3x Danieau´s 10ml 30x Stock solution plus 990ml distilled water 
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Tricaine 
Reagent Quantity for xM Tricaine solution 
Tricaine/MS-222 (PharmaQ, UK) 400mg 
Distilled water 100ml 
Tris (Alfa Aesar) pH adjusted to 9 2ml 
Adjust pH to 7  
Metronidazol 
Reagent Quantity for 10mM Mtz solution 
DMSO (Sigma Aldrich) 100µl 
0.3x Danieau´s 50ml 
Metronidazol (Sigma) 86mg 
 
The Metronidazol solution was made fresh at the day of use.  
 
Trichostatin A 
Stock solution: 
Reagent Quantity for 100µM Stock solution 
Trichostatin A (Sigma Aldrich) 1mg 
DMSO (Sigma Aldrich) 3.308ml 
 
Working solution: 
Reagent Quantity for 15nM solutions 
Trichostatin stock solution (100µM) 1.5µl 
Danieau´s  5ml 
DMSO (Sigma Aldrich) 0.2% 
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Mivacurium Chloride  
100x Stock solution  
Reagent Quantity for 50mg/mL stock solutions 
Mivacurium Chloride (Abcam) 25 mg 
Distilled water 500µl 
 
Working solution 
Reagent Quantity for 400µl of 0.5mg/mL solution 
Mivacurium chloride stock solution (100µM) 3µl 
Distilled water 37µl 
Danieau´s 360µl 
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3 RESULTS 
3.1 Developmental myelination and myelin sheath growth 
3.1.1  Developmental myelination   
 
Conduction velocity along axons is an important factor influencing nervous system function. 
Myelin sheath length is one factor affecting conduction speed, however, the mechanisms 
regulating myelin sheath length and node of Ranvier positioning remain unknown. 
Modulating myelin sheath length could therefore be a mechanism to adjust conduction 
velocity, but direct evidence for myelin remodeling is still lacking. I aimed to study 
mechanisms regulating myelin sheath length and node of Ranvier positioning during 
development and to investigate how dynamic myelin sheaths can be.  
The first step was to characterize the time course of myelination in the zebrafish spinal cord, 
as oligodendrocyte number or density might influence myelin sheath dynamics. Therefore, 
I assessed the number of myelinating oligodendrocytes in the zebrafish spinal cord at 
different ages during the first month of development.  
I used a zebrafish transgenic line in which all oligodendrocytes express EGFP, under control 
of myelin basic protein promoter elements Tg(mbp:nls-EGFP), and imaged the fish at 
different ages. To easily visualize and count the cells, the EGFP was fused to a nuclear tag 
(Fig 3.1 A) (Karttunen et al., 2017). As myelination in zebrafish shows a gradient from 
anterior to posterior (Almeida et al., 2011), I counted the cells in a defined area in the middle 
of the zebrafish spinal cord around somite 17.  
I found that in the first two weeks post fertilization, there is a substantial increase in the 
number of oligodendrocytes per 100µm of spinal cord (2.1 cells/d/100µm). In the third and 
the fourth week there is still an increase in oligodendrocyte number, but it is lower than in 
the first two weeks (0.6 cells/d/100µm) (Fig. 3.1 B). During this time, the fish also grow 
substantially. To quantify the size increase of the zebrafish, I measured the length of one 
somite in the field of view. Zebrafish grow on average by 3.5% per day (3.5 ± 2.4%/day) 
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(Fig. 3.1 C). The number of oligodendrocytes per somite, normalized for fish growth, shows 
an almost linear increase (1.8 ± 1.0 cells/d/somite) (Fig. 3.1 D). 
Together, this shows that zebrafish myelination continues at least until 4 weeks of age, with 
a continuous increase in oligodendrocyte number. The density of oligodendrocytes, on the 
other hand, seems to reach a plateau after the second week of development.  
  
Figure 3.1: Myelination time course in the first month of zebrafish development. 
(A) Confocal images of the spinal cord of a Tg(mbp:nlsEGFP) fish. Oligodendrocytes are labelled with EGFP 
localized to the nucleus. The different timepoints (3, 9, 15, and 29 dpf) show the increase in cell numbers in a 
defined area of the zebrafish spinal cord at somite 17. (B-C) Quantification of oligodendrocyte number over 
time. (B) Oligodendrocyte density, expressed as oligodendrocytes/100µm, shows a steep increase in the first 
two weeks of zebrafish development. After that the increase in cell numbers is less prominent until it appears to 
stop at the last two timepoints analyzed. (C) The fish growth is measured as length increase of one somite. With 
ongoing development, the fish increase in length (D) Oligodendrocyte number given as cells/somite, shows a 
continuous increase. Scale bar 50µm 
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Previous studies, in the mouse frontal cortex and zebrafish spinal cord (Murtie et al., 2007; 
Almeida et al., 2011), have shown that oligodendrocytes are able to produce myelin sheaths 
of different lengths. I wanted to verify that finding also for my experimental setup and 
determine the length range of myelin segments in the zebrafish spinal cord. Hence, I labeled 
single oligodendrocytes with mbp:tagRFPt-caax in a background in which all myelin was 
labeled with mbp:memCerulean. The fluorescent proteins are localized to the membrane 
for better visualization of the sheaths. To get an estimate of the variability of myelin sheaths 
in the zebrafish at 8dpf, I measured randomly chosen myelin sheaths. I also measured a 
subset of sheaths, as it was technically often not possible to measure all sheaths, formed 
by single oligodendrocytes. The sheaths measured at 8dpf were highly variable and ranged 
between 4 and 71 µm. I found that sheaths formed by a single oligodendrocyte span the 
whole range of myelin sheath lengths and therefore confirmed the observation that was 
made in other studies (Murtie et al., 2007; Almeida et al., 2011)  
 
Figure 3.2: Individual oligodendrocytes can form myelin sheaths of different lengths 
(A) Confocal image of a single oligodendrocyte (yellow) in a full transgenic mbp line (green). The 
oligodendrocyte forms myelin sheaths of different lengths. (B) Quantification of randomly measured myelin 
sheaths (black) and a subset of myelin sheaths formed by single oligodendrocytes (gray). The sheaths made 
by a single cell can span the whole range. Scale bar 10µm. See also (Auer et al., 2018) 
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3.1.2 Different phases of myelin sheath growth 
 
As one oligodendrocyte is able to produce sheaths of different lengths, this raises the 
question of how these differences are established. Theoretically, there are two ways of how 
sheaths with different lengths could be formed. Either the sheaths differ in growth rate, or 
some grow for longer periods of time than others. To investigate how the different sheath 
lengths are established, I followed newly differentiated oligodendrocytes over time and 
assessed the growth pattern of the myelin sheaths. To label the cells, I used olig1 promoter 
elements, that reliably label oligodendrocyte precursor cells (Fig 3.3 top). Even though with 
the promoter elements we were using only OPCs are labeled, I was still able to detect the 
remaining fluorescent protein after differentiation (Fig 3.3 bottom).  
 
Figure 3.3: Olig1 as a marker for Oligodendrocyte precursor cells   
Confocal images of an OPC at two different timepoints, before and after differentiation. The left images show 
the expression of memEYFP under control of olig1 promoter elements. The right images show olig1:memEYFP 
expression (yellow) as well as mbp:memCerulean (green) expression. Scale bar 10µm. See also (Auer et al., 
2018) 
 
To follow sheath growth over time I performed time-lapse imaging with two different settings. 
With the first, I aimed to document the very early growth dynamics. I transiently injected 
olig1:memEYFP into Tg(mbp:memCerulean) and performed time-lapse imaging at 30min 
intervals of oligodendrocyte precursor cells that were about to differentiate.  
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Upon differentiation the cells formed many short nascent sheaths, some of which were 
retracted again (Fig 3.4A, asterisk) while others grew longer over time (Fig 3.4A circle). I 
measured the sheath lengths at the different timepoints and plotted it versus the time after 
differentiation. I specified the timepoint of differentiation as the time when the cell had 
formed several nascent sheaths. In the first hours, up to 8h post differentiation (hpd), all 
sheaths showed a very similar growth rate (growth rate 0-8hpd 0.70±0.16µm/h) and 
therefore length, ranging between 5 and 11 µm.  
After this timepoint, the individual sheaths grew with very different rates and at the end of 
the imaging, 19h post differentiation, they had all established very different lengths ranging 
from 7 to 33 µm (growth rate 8-19hpd 0.70±0.53µm/h, p=0.000653). To verify the 
observation of similar growth rate between individual sheaths in the first 8h, I calculated the 
variance of sheath length at the different timepoints and, indeed, it was very low (avg 
variance 0-8hpd, 1.2±0.72µm2) until 8h post differentiation; after that there was a significant 
increase (avg variance 8-19hpd: 18.9±9.46µm2 p = 0.04373) 
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Figure 3.4 Time-lapse of an oligodendrocyte precursor cell differentiating into a myelinating 
oligodendrocyte  
 
(A) Confocal images of a differentiating OPC at 4 different timepoints (0,6,9.5 and 12.5 hpd). Upon differentiation 
the cell forms nascent sheaths, some of which are retracted again (*), some sheaths grow longer over time (o) 
(B) measurements of single sheaths over time in the first hours after differentiation. In the first 8hpd the sheaths 
display a similar growth rate, after that, the sheath length varies more between different sheaths. (C) 
Quantification of the variance of sheath length at different timepoints. Until 8hpd the variance is very low after 
that it shows a substantial increase. Scale bar 10µm. 
 
To follow the sheaths for longer than one day, I performed time-lapse imaging with different 
settings. I used the same injection paradigm, olig1:memEYFP injected into 
Tg(mbp:memCerulean) fish to get mosaic labeling of OPCs. I then imaged the fish once per 
day in the first days, later I increased the imaging intervals to every second day to reduce 
the stress for the fish. I screened the fish for OPCs, that had just differentiated and where I 
could see short myelin segments formed, and followed these segments over time.  
I found that in the beginning, the first 2-3 days after differentiation, the myelin segments 
were growing relatively fast compared to their growth after 3-4days post initiation (dpi) 
(growth rate 1-3dpi: 9.3 ± 4.2 µm/day; n = 77/13 sheaths/animals) (Fig 3.5 A,B). From 4 dpi 
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onwards, they were all growing slowly and their length increase was barely detectable 
(growth rate 4-10dpi: 1.6 ± 1.7µm/day; n = 74/12 sheaths/animals, p<0.001). As the OPC 
marker was injected into a transgenic line where all oligodendrocytes, and therefore also 
myelin, are labelled, I could also assess the environment of the sheaths, regarding how 
many neighboring sheaths they had. When the sheaths are growing along an axon and they 
reach a neighboring sheath they will form a node and stop growing. Neighboring sheaths 
could therefore act as a physical barrier of sheath growth. Some sheaths had no 
neighboring sheath, others had just one (Fig 3.5B) and some sheaths were surrounded by 
two neighboring sheaths (Fig3.5A). Strikingly, even when there was no neighboring sheath, 
and therefore no physical barrier, the sheaths slowed down their growth rate and seemingly 
stopped growing (Fig 3.5B).  
When I measured the length of the sheaths and plotted it versus the days post initiation 
(dpi) it also showed that the sheaths were growing fast in the first few days and after that 
they slowed down and showed only little length increase. Moreover, in the fast growth period 
(the first 3 days) the sheaths all grew at very different rates.  
A significant portion of their length was achieved in the first 3 days, as after that time the 
growth curves run almost parallel (Fig 3.5C). To verify that the growth dynamics and sheath 
lengths are indeed independent from neighboring myelin segments, I analyzed the sheath 
length at the end of analysis of all three groups (namely, sheaths with no neighboring 
sheath, sheaths with one neighbor, and sheaths with two neighbors). The sheath lengths 
for all three groups are not significantly different from each other (33.6 ± 10.8 versus 41.9 
± 17.9 versus 36.4 ± 19, n = 16/14/16 sheaths, p=0.3) (Fig 3.5D). To analyze the growth 
dynamics of the three different groups, I normalized the sheath growth to the end length 
and averaged the sheaths with zero, one, or two neighbors respectively. The curves almost 
perfectly overlapped (Fig 3.5E) and the sheaths had reached the majority of their end-length 
at 3dpi (83% ± 17% versus 78% ±15% versus 72% ± 15%, n = 12, 13, 14/39 sheaths, p = 
0.2) for an 8±1 day analysis. All sheaths displayed the same growth behavior: a fast initial 
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sheath growth then a slowing of the growth rate, independent of them having zero, one, or 
two neighboring sheaths. 
 
Figure 3.5 Myelin sheath growth over time 
(A,B) Confocal images of newly generated sheaths followed for a week. (A) The newly formed sheath reaches 
a neighboring sheath on both sides at 8dpf (B) The newly formed sheath reaches another neighboring sheath 
only on one side, nevertheless it substantially slows down its growth (C) Growth curves of single sheaths, 
generated at 5dpf and followed until 14dpf. All sheaths show a similar growth pattern, a fast, initial sheath growth 
followed by a slower extension phase. The cartoon indicates if the sheath had zero, one, or two neighboring 
sheaths at the end of the imaging period (D) Comparison of end length of the sheaths with zero, one, or two 
neighboring sheaths. The end length between the three groups is not significantly different (E) Averaged and 
normalized growth curves of sheaths with zero, one, or two neighboring sheaths show that the sheaths show all 
the same growth behavior. Scale bar 10µm. See also (Auer et al., 2018) 
 
As shown before, the overall density of oligodendrocytes in the spinal cord reached a 
plateau after the 2nd week of development (5dpf: 12.7 ± 2.8 versus 15dpf: 21.5 ± 3.1 
cells/100µm, p < 0.001). I wondered, if there is a difference in sheath length and growth 
dynamics of sheaths that are initiated at later timepoints, when oligodendrocyte density had 
reached a plateau. Early generated sheaths are formed when there are few myelin sheaths 
present and many permissive axons. Sheaths generated during the plateau phase might 
have less space to grow due to more surrounding myelin.  
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To investigate if oligodendrocyte density influences sheath growth and length, I imaged 
newly differentiated sheaths at different timepoints of zebrafish development. I started the 
imaging at 5dpf and 14dpf, respectively, and continued imaging the sheaths in both groups 
for 9-10 days and assessed their length at the end of the analysis. Sheaths formed at 5dpf 
and 14dpf showed both huge variabilities in terms of length, but had overall the same end 
length (37.2 ±13 vs. 34.2±11.1, p-value 0.596) (Fig 3.6A). To analyze differences in the 
growth dynamics of early and late generated sheaths I plotted the growth curves of single 
sheaths (Fig 3.6B) as well as the averaged growth curves for both groups (Fig.3.6B’). There 
was no difference between the two groups observed, showing that oligodendrocyte density 
influences neither sheath growth nor sheath length.  
 
Figure 3.6 Comparison of early and late generated sheaths during zebrafish development  
(A) Quantification of the sheath length of sheaths initiated at two different timepoints during development (5 and 
14dpf). Sheath length, after 9-10 days of growth, does not differ between cells generated at 5dpf, when there is 
a fast addition of new oligodendrocytes, and 14dpf, when only few new oligodendrocytes are added. (B) Growth 
curves of single sheaths generated at 5 and 14dpf, respectively. Almost all sheaths show the same dynamics, 
a fast initial growth followed by a slower growth phase (C) Quantification of the averaged and normalized growth 
curves. The growth curves for both groups overlap, there is no difference in growth behavior between early and 
late generated sheaths. See also (Auer et al., 2018) 
 
To proof, that it is indeed the growth rate that differs between the sheaths and that 
determines its length, I analysed the daily growth rates in the first 10 days of sheath growth. 
I calculated the growth rate on day x as the length at day x minus the length at the day 
before. In the first three days the growth rate is very variable and high (growth rate 1-3dpi: 
9.3 ± 4.2µm/day; n = 77/13 sheaths/animals), after that there is less variability in growth 
rate and the it is overall significantly slower (growth rate 4-10dpi: 1.6 ± 1.7 µm/day; n = 
74/12 sheaths/animals, p<0.001) (Fig 3.7 A).  
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As the highest variability in growth rates was observed in the first 3 days of sheath growth, 
I correlated the sheath growth during these first days with the sheath length at 8dpf (r=0.87, 
n = 16 sheaths, p<0.001) (Fig 3.7B). I found a high correlation between the two values 
supporting the hypothesis that sheath length is determined in the first 3 days after initiation 
by differences in growth rate.  
 
Figure 3.7 Quantification of growth speeds of myelin sheaths 
(A) Quantification of growth rates of myelin sheaths in the first 10 days after initiation. In the first three days the 
sheaths show highly variable but fast sheath growth. After that, sheath growth slows down and becomes more 
uniformly. (B) The growth rate in the fast growth phase correlates with the sheath length at 8 days post initiation 
supporting the hypothesis that sheath length differences are established in the fast sheath growth phase. *** p 
< 0.001. See also (Auer et al., 2018) 
 
I wondered, if sheath length differences are already established in the first three days by 
the fast growth phase, why the sheaths continue to grow slowly after the three days of fast 
growth.  The slow growth phase could be due to the body growth of the fish; as previously 
mentioned, the fish do grow substantially during the long imaging periods. From 4dpf to 28 
dpf they almost double in length (Fig 3.8A). To measure the length increase or growth of 
the fish I measured the length of one somite on the respective days (Fig 3.8B). To do this, 
I simultaneously acquired images of the somites by collecting the transmitted light with the 
confocal microscope. 
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Figure 3.8: Fish growth over time  
(A) Pictures of larval zebrafish. The top image shows a larval zebrafish at 4 days post fertilization. The bottom 
image shows a zebrafish larva at 28 dpf. Zebrafish show a substantial increase in body size in the first month 
of development. Scale bar 1mm. (B) Transmitted light images were simultaneously acquired. The end of the 
somite is indicated by the white dotted lines. To measure the growth of the fish, the length of the somite was 
measured at different timepoints. Scale par 10µm.  See also (Auer et al., 2018) 
 
To test if the slow growth phase does correlate with the growth of the fish, I measured the 
somite length and calculated the relative length by normalizing it to the end length, i.e. the 
length at 10 days after initiation of the respective sheath. I then plotted the relative somite 
length together with the relative sheath length, also normalized to the length at 10 days after 
initiation, revealing that the curves overlap after 3-4 days post sheath initiation (Fig 3.9A). 
To further verify that the slow growth phase is due to the fish’s body growth, I calculated the 
relative differences between the somite length and the respective sheath length for the 
different days. In the first two days there is large difference between the two relative lengths, 
but from three days post initiation onwards there is no measurable difference (Fig 3.9B).  
I could further separate the sheath growth into a fast growth phase from 0-3 (dpi) followed 
by a slower elongation phase from 4 days onwards. As the elongation phase perfectly 
overlaps with the body growth of the fish it probably compensates for it. To test the 
hypothesis, that the elongation compensates for fish growth, I calculated predictions for the 
sheath lengths in the elongation phase. Therefore, I calculated the relative fish growth, now 
normalized to the length at day 4 post initiation, which is the first day of the elongation 
phase. I then multiplied the relative size at a certain day with the sheath length at day 4 post 
initiation. I calculated the predictions for sheaths at two different timepoints, 6 and 10dpi, 
and correlated them with the measured value at the respective day (Fig 3.9C). For both 
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days the measured and the predicted value correlated with a high correlation coefficient 
(6dpf: r = 0.95, 10dpf r= 0.98, p<0.001 n=13 and 10). Together this shows that as soon as 
a new sheath has reached the elongation phase its behavior becomes highly predictable 
based on the body growth of the fish.   
 
Figure 3.9: Myelin sheath growth consist of an elongation phase to compensate for body growth 
(A) The growth curves of myelin sheaths (gray) and the somite length (red) do overlap after the third day post 
initiation when normalized to end length. Myelin sheath growth shows a growth phase and an elongation phase. 
(B) The difference between the relative somite length and the relative sheath length is significant in the first two 
days, after that its indistinguishable from zero. (C) Sheath length in the elongation phase is highly predictable 
by knowing the somite length of the fish. Predicted values highly correlate with measured values at two different 
timepoints after sheath initiation, 6 and 10dpi. ** p < 0.01, *** p < 0.001 See also (Auer et al., 2018) 
 
Together, I could show that myelin sheath length consists of three different growth phases 
that are independent of physical barriers like neighboring sheaths. In the first early growth 
phase, that lasts for about 8h the sheaths all grew very uniformly with a very low variability. 
In the second fast growth phase, that lasts about 3 days, the sheaths all show a high 
variability and very different growth rates. This second phase also determines the 
differences in sheath length. In the last growth phase, which is rather passive, the sheaths 
are elongating only to compensate for body growth. In this third growth phase the sheath 
length becomes therefore highly predictable by the body growth of the fish.  
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3.1.3 Axonal myelination patterns 
 
In the previous section I could show that myelin sheaths have different growth rates that 
determine sheath length differences. This raises the question, of how these different growth 
phases are regulated. As one cell can make sheaths of different lengths, it is unlikely to be 
oligodendrocyte intrinsic. Another option could be axonal regulation of myelin sheath length. 
In line with that, earlier studies reported a correlation between axon diameter and myelin 
sheath length (Murray and Blakemore, 1980; Ibrahim et al., 1995).  
To assess how sheath length varies along an axon, I measured the length of consecutive 
sheaths along different axons. As it is not possible to measure this in the full transgenic mbp 
lines due to the high density of labeled myelin, I labeled the nodes of Ranvier and measured 
nodal distance. I labeled the nodes by transient injections of Nfasca-EYFP, a fusion protein 
of the transmembrane nodal protein Neurofascin and EYFP, under control of contactin 1b 
promoter elements (cntn1b) (Czopka et al., 2013). Cntn1b is a neuronal promoter used for 
labeling large caliber axons. To better follow the axons along their length, I co-expressed 
another cytoplasmic fluorescent protein, also driven by cntn1b promoter elements. The two 
constructs were co-injected into full transgenic mbp lines. As injections of these constructs 
give a random expression pattern, I screened the fish for myelinated neurons that express 
both markers.  
I assessed the localization of the marker and was able to show that Nfasca-EYFP labels 
unmyelinated stretches of axons (Fig 3.10 A) and when the axon is fully myelinated it 
eventually localizes only to the nodes of Ranvier. (Fig 3.10 B).  
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Figure 3.10: Expression of Neurofascin tagged with YFP to label unmyelinated axon stretches 
(A,B) Confocal images of an axon co-expressing mCherry and Nfasca-EYFP at two different timepoints (4 and 
6 dpf) (A) Nfasca expression (red) in a neuron (cyan) with larger unmyelinated stretches. Nfasca is localized to 
the unmyelinated regions and nodes (white arrows). When there is a myelin sheath (yellow) there is no Nfasca 
signal. (B) At 6dpf the neuron is fully myelinated and the only red signal is localized at the nodes of Ranvier. 
Scale bar 10µm. See also (Auer et al., 2018)  
 
Using this method, I was able to follow neurons for almost 0.5mm along their length. Figure 
3.11A shows a fully myelinated neuron labelled with mCherry (depicted in cyan). The white 
arrows indicate Nfasca signal (depicted in red) and the location of the nodes. I measured 
the distance between consecutive nodes, an indicator of myelin sheath length, along 
several axons, from different neuron types.  
I found that the myelin segments on fully myelinated axons showed a high variability and 
ranged between 6 and 87 µm (37.7 ± 16.8 µm n=143/15/15 sheaths/axons/animals) (Fig 
3.11 B). Nevertheless, there were also differences between different neurons. Some axons 
had overall shorter myelin segments than others (Fig. 3.11 B). Multiple comparison of the 
sheath length of the different axons showed that 7/15 axons had significantly different 
sheath lengths. I could not detect any correlation with the neuronal type - different 
interneurons like Commissural primary ascending (CoPA), Circumferential descending 
(CiD) and other interneurons were analyzed - indicating that sheath length along an axon 
seems to be a feature of every individual axon (e.g. #1 and #4 are the same type). 
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As mentioned before, it was proposed that axon diameter influences myelin sheath length 
(Murray and Blakemore, 1980; Ibrahim et al., 1995). In my experiments I could not detect a 
correlation between average myelin sheath length and axon diameter (r = -0.02; p = 0.95. 
Fig 3.11 C). All axons measured had a similar diameter (0.9 ± 0.1 µm) 
 
Figure 3.11 Myelin sheath length along individual axons 
(A) Confocal image of a neuron expressing mCherry and Nfasca-EYFP. The white arrows point to the Nfasca 
signal, that labels the nodes of Ranvier. (B) Quantification of myelin sheath length along individual axons. Myelin 
sheath length differs between different axons but it spans wide ranges of the total myelin sheath lengths 
measured (C) Quantification of average sheath length and the respective axon diameter. There is no correlation 
between sheath length and axon diameter. Scale bar 100µm. * p < 0.05, ** p < 0.01 See also (Auer et al., 2018) 
 
It was recently shown that besides fully myelinated axons, there are also axons in cortical 
layers in the mouse with a partial myelination profile (Tomassy et al., 2014). As this was no 
longitudinal study, these patterns could also be snapshots of an axon that is slowly being 
myelinated. To see, if I could also find partially myelinated axons in the zebrafish spinal cord 
and to follow them over time, I injected a DNA construct encoding an axon marker in 
transgenic lines with all myelin labeled (Tg(mbp:memCerulean)). 
I did find partially myelinated axons and followed them for several days from 6dpf onwards. 
In some cases, (3/6), the axons did get more ensheathments over time (Fig 3.12A blue) but 
in other cases, (3/6) the axons maintained a stable number of myelin sheaths during the 
time window of observation (Fig 3.12A red). From this investigation it is clear that some 
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axons eventually do get fully myelinated while others maintain their partial myelination 
status, at least until the end of the analysis. (Fig. 3.12B).  
As the myelin segments on these partially myelinated axons often did not have physical 
barriers like neighboring sheaths, I also measured their length, to assess if the absence of 
physical barriers has a positive influence on sheath length. The sheath lengths on these 
axons were highly variable, but they were not longer than the myelin sheaths on fully 
myelinated axons, confirming previous observations during sheath growth analysis. 
Although there was no physical barrier stopping them from growing (these experiments 
were done in the full transgenic line), the sheaths did not grow longer than the ones on fully 
myelinated axons (9 – 68 µm, 23.9 ± 14.9, n = 11/11 axons/animals) (Fig 3.12C).  
To rule out incomplete labeling of our full transgenic lines, I performed Spectral Confocal 
Reflectance Microscopy (SCoRe) (Schain et al., 2014) of partially myelinated axons. In 
SCoRe imaging the light reflected by the tissue is collected, and as myelinated axons reflect 
more light than unmyelinated axons and surrounding tissue, this is a suitable tool for label 
free visualization of myelinated axons. Whenever I could detect a SCoRe signal there was 
also EGFP signal, confirming that the labeling was complete and that unmyelinated axon 
stretches are indeed unmyelinated (Fig 3.12D). 
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Figure 3.12 Partial myelination patterns in the zebrafish spinal cord.  
(A) Confocal images and reconstructions of partially myelinated axons. The reconstructions show the 
myelination over time. The left example shows an axon that gets increasingly myelinated (blue). The right 
example shows an axon that maintains its partial myelination pattern (red) (B) Quantification of myelin coverage 
over time. Some axons (3/6) get increasingly myelinated while others maintain their partial myelination pattern 
(C) Quantification of myelin sheath length along partially myelinated axons. Sheaths formed on partially 
myelinated axons have similar lengths than sheaths on fully myelinated axons (D) Confocal image and SCoRe 
image of a full transgenic mbp line (Tg(mbp:EGFP-caax)). All myelin sheaths are labelled with EGFP and 
detected with SCoRe, confirming full labeling of the used transgenic lines. Scale bar 10µm. See also (Auer et 
al., 2018) 
 
To follow axon myelination patterns over time, I co-expressed mCherry and the fusion 
protein Nfasca-EYFP in neurons. I was able to image axons for up to 450µm of length (Fig 
3.13 A) and to assess the nodal position with the EYFP signal. I followed the axons over 
time and imaged them in regular intervals. When the images are aligned to a landmark, 
here the soma of another neuron between myelin sheath #6 and #7, one can see that the 
nodes do not keep the same position but they move slowly along the axon, reflecting the 
body growth of the fish and therefore sheath elongation (Fig 3.13B). To quantify and better 
compare axon myelination patterns I plotted the sheath length versus the sheath number 
along the axon (Fig 3.13C).  
I observed very specific myelination patterns for the neurons and, as the sheaths were still 
growing in the beginning, the patterns changed over time (Fig 3.13 C, shades of gray). At 
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later timepoints, when all sheaths are in the elongation phase, I corrected the single sheaths 
for body growth. The newly obtained pattern looks much more stable over time (Fig3.13 D).  
I did this for several neurons and found that all neurons had a unique myelination pattern; 
but what they all had in common is, that once the pattern is established, it is remarkably 
stable over time when it is corrected for body growth of the fish (Fig 3.13 E-E’’’).  Sometimes 
I observed two nodes merging to become one node, indicating sheath retractions, as it was 
previously reported (Czopka et al., 2013). These retractions temporarily disrupted the 
pattern (Fig. 3.13 E’, sheath #8) but once the sheath fully retracted the pattern was stable 
again.  
 
 
Figure 3.13 Timeline of axonal myelination patterns 
(A,B) Confocal images of a neuron labelled with cntn1b:mCherry and cntn1b:Nfasca-EYFP. The white arrows 
point to the EYFP signal and therefore to the node position. (A) Confocal image of a labelled CoPA neuron, 
showing the first ~450µm of the axon at 5dpf. (B) Timeline of the same neuron from 7-14dpf showing a subset 
of sheaths. Images are aligned to the soma between sheaths #6 and #7. Sheath growth of single sheaths can 
be observed by the nodes moving. (C) Graph showing myelin sheath length plotted against sheath number. The 
neuron shows a very specific myelination pattern, that changes over time. (D) Graph showing sheath length 
corrected for body growth plotted versus sheath number. The pattern is stable over time. (E-E’’’) Myelination 
patterns from different neurons, corrected for body growth. The patterns are stable over time. (E’) Sometimes 
sheaths retract, resulting in a temporarily disruption of the pattern. All axons analyzed had a unique myelination 
pattern. Scale bar 100µm. See also (Auer et al., 2018) 
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When I followed the axons over time, I observed that different neurons showed different 
myelination dynamics. Some axons got myelinated very fast, while others maintained long 
unmyelinated axon stretches. To investigate if these differences are specific for different 
neuronal types, I chose three different types that are easy to distinguish by their morphology 
and assessed their myelination dynamics. I investigated the myelination dynamics of two 
interneurons, Commissural Primary Ascending (CoPA) and Circumferential Descending 
(CiD), as well as the sensory Rohon-Beard (RB) neuron. CoPA neurons receive sensory 
input from RB cells (Gleason et al., 2003) and project to CiD neurons (Pietri et al., 2009). 
Their soma lies in the dorsal part of the spinal cord. CoPA axons cross the midline in the 
ventral spinal cord and project to the contralateral anterior spinal cord (Fig 3.14A). CiD 
neurons receive, besides input from CoPAs, also supraspinal input from Mauthner cells and 
they project to motor neurons (Ritter et al., 2001). The somata of these neurons are located 
between the ventral and dorsal spinal cord and their axon projects to the posterior spinal 
cord, with one bifurcation projecting to the anterior (Fig 3.14B). RB neurons are sensory 
neurons that sense touch and elicit, via CoPA and CiDs, an escape response (Ritter et al., 
2001; Douglass et al., 2008). RB cells are located in the dorsal spinal cord (Fig 3.14C) and 
they are, during the course of development, replaced by Dorsal Root Ganglion (DRG) 
neurons  (Williams et al., 2000) (Svoboda et al., 2001). 
To assess the myelination dynamics of these three different neuronal types, I injected 
cntn1b:Nfasca-EYFP together with another cytoplasmic fluorescent protein under control of 
cntn1b promoter elements in a full transgenic mbp line (Tg(mbp:memCerulean)). I used the 
Nfasca-EYFP label and the myelin label as a double control for assessing myelinated parts 
of the axon. I screened the fish at 4dpf for expression of the two neuronal markers in the 
respective neurons. I imaged the neurons at 4,6 and 8dpf and measured the percentage of 
axon, in the field of view, that was covered with myelin.  
I plotted the percentage of ensheathment versus the days post fertilization and found that 
CoPA neurons were all myelinated very fast. Already at 4dpf all of them were covered to at 
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least 50% with myelin, and by 8dpf almost all were fully covered with myelin (Fig 3.14 D). 
For the CiD neurons, I observed a very diverse pattern. At 4dpf almost all of them were 
covered by less than 50% with myelin.  The individual neurons were myelinated at different 
rates, and at 8dpf most of them were covered between 50 and 85% with myelin (Fig 3.14 
E). RB were never ensheathed by more than 10% with myelin. Often the sheaths that had 
formed were transient and retracted again (Fig 3.14 F). I also measured the diameter of the 
analyzed axons and found that at 8dpf CoPAs have a larger diameter then RB axons. CiD 
axons are more variable in their diameter (CoPA: 0.81 ± 0.06µm CiD: 0.69 ± 0.11µm RB: 
0.64 ± 0.07, p = 0.020 Overall, I found that the axon diameter correlates with the amount of 
myelin formed along the axon (r = 0.678, p = 0.0095) (Fig 3.14 G). 
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Figure 3.14 Myelination profiles of different neuronal types  
(A-C) Cropped confocal images of different neuronal types in the zebrafish spinal cord (A) CoPA neuron with 
typical morphology (B) CiD neuron (C) Rohon-Beard neuron (D-F) Quantification of percent ensheathment at 
4,6 and 8dpf. (D) CoPA axon analysis. CoPA axons show almost full myelination by 8dpf (E) CiD axon analysis. 
CiD axons are myelinated at different rates. Some are myelinated very fast, while others have only few 
ensheathments at 8dpf (F) RB axon analysis. RB axons had only few and short ensheathments that were often 
transient. (G) Correlation of ensheathment and axon diameter. There is a correlation between axon diameter 
and ensheathment. Scale bars 10µm 
 
As mentioned before, activity is one regulator of myelination. To assess if the spontaneous 
activity correlates with the amount of ensheathment, I performed calcium imaging. I 
therefore used Tg(cntn1b:KaltA4) crossed with Tg(UAS:GCaMP6s) fish to obtain mosaic 
labeling of neurons labeled with GCaMP6s. To obtain z-stacks with a fast imaging rate I 
used a lightsheet microscope for the calcium imaging. As the anesthetic used for confocal 
imaging (Tricaine) blocks neuronal voltage gated sodium channels (Attili and Hughes, 
2014), I paralyzed the fish for the calcium imaging with Mivacurium chloride, to prevent 
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movement artefacts without affecting neuronal signaling, and imaged at a frequency of 
0.5Hz. For each fish I took two movies of each 10min with a 10min break in between. The 
fish were imaged between 4 and 5dpf.  
I analyzed the somatic Calcium events for CoPA, CiD and RB neurons (Fig 3.15 A,B). I 
found that the amount of spontaneous Calcium transients greatly differed between the three 
different types. CoPAs were mostly silent (6/7) and the one cell that showed calcium events 
had only two transients during 20min of imaging. Almost all of the analyzed CiD neurons 
were active (5/6) and they had a highly variable number of Calcium transients (0-37 Ca2+ 
transients/20min). From the analyzed RB neurons, about half of them were active with the 
number of Ca2+ transients ranging between 0 and 15 per 20min (CoPA: 0.013 ± 0.035/min 
CiD: 1.017 ± 0.834/min RB: 0.124 ± 0.195/min, p = 0.0049). To assess if spontaneous 
activity influences the amount of ensheathment, I correlated the amount of Calcium 
transients with the % ensheathment measured in the above-mentioned experiment (Fig 
3.15 C). There was no correlation detected (r=-0.5, p>0.999), as the most silent neurons 
(CoPA) were the ones with highest amount of ensheathment. The CiD neurons varied 
greatly in terms of activity and ensheathment, but as the data was obtained from 
independent experiments I could not assess if activity correlates with ensheathment for the 
CiD neurons.  
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Figure 3.15 Analysis of calcium imaging in CoPA, CiD and RB neurons 
(A) Examples images of GCaMP6s from CoPA, CiD and RB (B) Quantification of neurons with the number of 
cells active and silent (C) Quantification of calcium events per 20 min in the three neuronal types. CoPAs show 
almost no Ca2+ transients; CiDs show a high variability in terms of Ca2+ events; RBs also show some variability, 
but overall fewer compared to CiDs. (D) Correlation of ensheathment with activity. The amount of Ca2+ events 
does not correlate with the amount of ensheathment. Mean ± SD Scale bar 10µm 
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Together, I could show that there are different myelination patterns in the zebrafish spinal 
cord. Besides fully myelinated axons also partial myelination patterns exist and are 
maintained for more than a week. Myelination patterns and node of Ranvier positioning 
seem to be independent of the neuronal type, however regarding the amount of 
ensheathment there are parallels between neurons of the same type. The amount of 
ensheathment does not only depend on the neuron type but also correlates with the axon 
diameter. Spontaneous activity, on the other hand, did not show a correlation with the 
amount of ensheathment between different neuronal types.    
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3.2 Myelin sheath length plasticity following oligodendrocyte ablation 
3.2.1 Remodeling of myelin sheath patterns 
 
As mentioned before, evidence for remodeling of existing myelin sheaths is still lacking. To 
test if myelin sheaths, once they have reached their elongation phase, are still able to 
actively grow and remodel their length, I aimed to remove neighboring myelin segments, in 
order to expose permissive axon and investigate if sheaths can reinitiate sheath growth and 
will invade the demyelinated territory.  
I established an ablation method with which I can precisely ablate single oligodendrocytes, 
which allows for the precise removal of its sheaths along the axons. To ablate single cells 
with high spatial and temporal precision, I expressed the photosensitizer KillerRed (Bulina 
et al., 2006; Teh et al., 2010) in oligodendrocytes. KillerRed is a red fluorescent protein that 
produces reactive oxygen species upon illumination with green light (540-580nm). I injected 
the newly synthesized construct mbp:KillerRed in Tg(mbp:EGFP-caax) fish to label single 
cells with KillerRed in a background were all myelin is labelled. I first tried to bleach the cells 
with green light (Teh et al., 2010), but the efficiency of cell ablation was very low so we 
decided to combine KillerRed expression with 2Photon laser bleaching. To ablate labeled 
cells, I targeted the 2Photon laser to the cell soma and scanned with a horizontal line 
through the center of the soma. The 2Photon laser, set to 770nm, bleached the cell for 
500ms. The bleaching of KillerRed led to ROS production which eventually killed the cell 
and led to the fragmentation of the soma and the myelin sheaths (Fig 3.16A).  
Using this method, I was able to ablate single oligodendrocytes without harming the 
surrounding cells. Only the targeted KillerRed labeled cells died and their myelin sheaths 
disintegrated, leaving demyelinated axon stretches behind. KillerRed negative cells are not 
affected and their myelin sheaths remain intact (Fig 3.16 B).   
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Figure 3.16 Oligodendrocyte ablation using KillerRed 
(A) Schematic of the KillerRed ablation method.  A horizontal scanning line is drawn through the oligodendrocyte 
soma. Upon bleaching KillerRed produced ROS that led to cell fragmentation (B)1 Confocal images of a 
KillerRed mediated cell ablation. The images show two KillerRed labelled cells (yellow) in a transgenic line with 
all myelin labelled with EGFP (green) before, directly after and one day after the ablation. The asterisks label 
the two targeted cells. After the cells were bleached with the 2-Photon laser they fragment and by 1 day post 
ablation the myelin sheaths are removed. The surrounding segments remain unaffected. Scale bar 10µm. See 
also (Auer et al., 2018) 
 
To test how dynamic myelin sheaths can be upon manipulation, I developed an 
experimental setup where I removed single sheaths along a fully myelinated axon and 
followed the demyelinated gap and the neighboring sheaths over time. Therefore, I injected 
mbp:KillerRed in Tg(mbp:EGFP-caax) fish and screened the fish to find single KillerRed 
                                                
1 Images were taken by my colleague Stavros Vagionitis 
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positive cells that formed a myelin sheath between two KillerRed negative sheaths (Fig 
3.17A).  
I will discuss the series of events with a specific example in detail, which is illustrated in 
Figure 3.17. I started the imaging at 4dpf. As I did not know when the sheaths were initiated 
I followed them until 8dpf to ensure that they were in their elongation phase, when their 
growth behavior is predictable. At 8dpf I performed the cell ablation of the KillerRed labeled 
oligodendrocyte and its sheaths and then followed the demyelinated gap for several days 
after the ablation. I observed that the neighboring sheath invaded the demyelinated territory 
and that a new myelin sheath was formed. The new myelin sheath was growing longer even 
though it already had reached the neighboring sheaths resulting in a pushing back of the 
adjacent sheaths. At the end of the imaging, the new myelin sheath had grown to a similar 
length as the ablated sheath, restoring the pre-ablation myelination pattern (Fig 3.17B). For 
better analysis of the growth dynamics of the neighboring sheaths I plotted the growth curve 
of the left neighboring sheath #1 – I only analyzed the dynamics of #1 in this case as the 
other neighboring sheath #3 was only born at the day of the ablation and hence not in the 
predictive growth phase (Fig 3.17 C gray line). As sheath #1 was born before 4dpf I knew 
that it was in its elongation phase and therefore in its predictive phase. It showed its normal 
slow growth behavior typical for the elongation phase but upon ablation of sheath #2 it 
changed its behavior and showed a rapid increase in length. After this short rapid increase 
in length it slowed down again and even shrunk a bit. I compared the measured growth 
curve with the predicted growth curve and saw that upon ablation it clearly deviates from 
the predicted length but later it approaches again similar values (Fig 3.17 C dotted line). As 
the newly formed sheath seemed to grow longer than normal and also pushed back the 
neighboring sheath I also analyzed its dynamics compared to the prediction. I plotted the 
prediction for the ablated sheath (Fig 3.17 D orange curves) as well as the growth curve 
and the respective prediction for the new myelin sheath (Fig 3.17 D gray lines). For the new 
myelin sheath, to be in the predictive elongation phase, I calculated the prediction from 4dpi 
onwards. The growth curves supported what I could observe with the confocal images: the 
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newly formed sheath grows for longer and does not seem to reach its elongation phase. It 
reaches a length similar to the prediction of the ablated sheath.  
 
 
Figure 3.17 Remodeling after sheath ablation 
(A,B) Confocal images of a full transgenic Tg(mbp:EGFP-caax) line injected with mbp:KillerRed (A) Overview 
of a KillerRed labelled oligodendrocyte in the zebrafish spinal cord at 7dpf. (B) Close up of the white box and 
timeline of the myelin sheath. The imaging started at 4dpf. At 8dpf the KillerRed labelled oligodendrocyte was 
ablated and its myelin sheaths disappeared leaving an unmyelinated gap at 10dpf. At 12dpf a new sheath was 
formed in the gap and the axon was fully remyelinated. The newly formed sheath did not stop growing although 
it had reached the neighboring sheaths. The neighboring sheaths shrink and at 19dpf the myelination pattern 
looks similar to the pattern before ablation. (C) Growth curve of the neighboring sheath #1 (gray line) together 
with the predicted growth curve (dotted gray line). After the ablation the measured sheath length deviates from 
the predicted length, but a few days later the measured and predicted lengths approach similar values (D) 
Growth curve of the ablated sheath (orange) and the remyelinating sheath (gray) together with their respective 
predictions (dotted lines). The new sheath deviates from its prediction, it is growing longer and thereby reaching 
a length similar to the prediction of the ablated sheath. Scale bar 10µm. See also (Auer et al., 2018) 
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To better analyze the deviating dynamics of the neighboring segments, I calculated their 
deviation from the respective predicted value and plotted it versus the days post ablation 
(Fig. 3.18). To visualize how significant the deviations are, I also calculated the difference 
of the measured value and the predicted value for myelin sheaths without ablation during 
the same days. I used the 8th day post fertilization as a reference day and calculated the 
95% confidence interval (CI) of the deviations. In the beginning the interval is very small 
indicating a good prediction, later is becomes wider indicating less precise predictions. I 
plotted the deviations from the different ablation cases together with the 95% CI.  One can 
see that directly after the ablation the predictions and the measured value clearly deviate 
from each other (in the case of 4/5 sheaths). The neighboring sheaths grow at faster rates 
than predicted (4.5 ± 3.0 versus 0.6 ± 0.5 mm/day at 1–3 days post ablation (dpa), p = 0.04, 
n = 5/4 sheaths/animals). This was only a very short-term effect, as 3 days later the sheaths 
slowed down again and some even shrunk. For some sheaths, when I was able to follow 
them for long enough, I could even observe them reaching lengths similar to what would be 
predicted.  
As mature oligodendrocytes do not produce new myelin sheaths, a new oligodendrocyte 
precursor cell needs to differentiate to remyelinate the demyelinated axons (Czopka et al., 
2013). The new myelin segments only reach their predictive behavior after 4 days of growth, 
hence, I could only analyze the growth from 4dpi onwards. I observed that the sheaths were 
also growing at faster rates than predicted. They prolonged their active growth phase and 
reached the elongation phase later (2.3 ± 0.9 versus 0.6 ± 0.1 µm/day growth from 4 to 5 
dpi for up to 15 days, p = 0.04, n = 4/3 sheaths/animals).  
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Figure 3.18 Quantification of the deviations from the predictions 
(A) Quantification of the deviation of neighboring sheaths from their predicted dynamics. 4/5 sheaths 
substantially deviate from their predictions after the ablation. In the first 5 days post ablation all sheaths are 
longer than the predictions and outside of the 95% confidence interval (pink area). A few days after the ablation 
the sheaths shrink again and reach their predicted values (B) Quantification of the deviation of the remyelinating 
sheaths from their predicted dynamics. 3/4 sheaths grow longer than predicted and their lengths are outside of 
the 95% confidence interval (pink area). See also (Auer et al., 2018) 
 
There was a typical series of events I could observe after cell ablations. In the first 1-2 days 
after the ablation the neighboring sheaths reinitiated fast sheath growth and invaded the 
demyelinated territory. I was able to observe this behavior in 13/17 cases. In the remaining 
four cases the neighboring sheaths did not invade the demyelinated territory (Fig 3.19A). 2-
4 days post ablation I observed that a new myelin sheath was formed to remyelinate the 
demyelinated gap. A new oligodendrocyte precursor cell had differentiated to form a myelin 
sheath in the demyelinated area. In the remaining three cases I could not observe a new 
sheath being formed, as the neighbors grew so fast that they had already remyelinated the 
gap before a new sheath could be formed (Fig 3.19 B). From 5 days post ablation onwards 
I could observe, in 80% of the cases, a pushing back of the neighboring sheaths by the 
newly formed myelin sheaths. In 6 out of the 8 cases the newly formed sheath pushed back 
neighbors that had grown in to the demyelinated gap, in the remaining 2 cases the new 
myelin sheath pushed neighbors back that had not invaded the demyelinated territory. In 
some cases, I could even observe a reestablishment of the pre-ablation pattern after the 
neighbors had grown into the gap and the newly formed sheath pushed them back again.  
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Figure 3.19 Summary of the remodeling events 
(A) Schematic of the events in the first 1-2days post ablation. The ablated sheath is removed and leaves an 
unmyelinated gap. Following that the neighboring sheaths reinitiate fast growth and invade the demyelinated 
territory (red parts of the sheath show active growth). (B) Schematic of the events 2-4 days post ablation. 
Following the removal of the ablated sheath, a new sheath is formed and remyelinates the demyelinated axon 
stretch. (C) Schematic of the events from 5 days post ablation onwards. After the invasion of the neighboring 
myelin segments and the formation of a new myelin sheath, the new sheath continues to grow and pushes the 
neighbors back.  
 
Together, I was able to show that, upon manipulation, the normally very predictive and 
stable myelin sheaths are able to remodel and deviate from their predicted pattern of growth. 
In some cases, I could even observe a reestablishment of the pre-ablation pattern indicating 
homeostatic myelin sheath length regulation.  
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3.2.2 Restoration of partial myelination patterns 
 
As I could observe a reestablishment of the pre-ablation pattern, I wondered if there is 
something like a ‘memory’ of where the sheaths had been.  
To test if there is something on the axon marking the territory where a myelin sheath has 
been, I performed oligodendrocyte ablation to demyelinate only partially myelinated axons. 
Due to the partial myelination, the newly formed sheath would have large stretches of an in 
general permissive axon to remyelinate it. To do this, I injected an axon marker, 
cntn1b:EGFP, into Tg(mbp:tagRFP-t-caax), Tg(mbp:KillerRed) lines. I used the 
combinations of these lines to facilitate ablation of an oligodendrocyte that forms sheaths 
on a partially myelinated axon. I used the KillerRed line together with the mbp:tagRFPt-caax 
line to have a membrane tagged fluorescent protein, which helps visualizing the myelin 
sheaths. 
I performed the ablation of the oligodendrocytes with the same technique as mentioned 
before. Upon ablation, the oligodendrocytes died leaving a demyelinated axon behind. A 
few days later, a new oligodendrocyte differentiated and new myelin sheaths were formed 
on the demyelinated axon. By aligning the images to landmarks, like the somata of 
neighboring neurons, I found that the new sheaths were formed at similar positions to where 
the ablated sheaths had been. For the analysis of the partially myelinated axons and their 
de- and remyelination I reconstructed the axon and the sheaths formed on it, using the 
Imaris software, as the labeling was often too dense to follow the axon with its sheaths. In 
some cases, I found additional myelin sheaths formed indicating that the axon was slowly 
getting myelinated (Fig 3.20B).  
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Figure 3.20 Partial myelination patterns are restored upon ablation  
(A) Confocal image of a partially myelinated axon at 8dpf. The white arrows point to the beginning and end, 
respectively, of the two myelin sheaths (B) Reconstructions of the axon from (A) with the timeline from 6dpf to 
17dpf. Cell ablation was performed at 8dpf. Upon cell ablation the axon is demyelinated. At 15dpf two new 
sheaths are formed at similar positions to where the ablated sheaths were. At 17dpf the sheaths had reached 
lengths similar to the ablated sheaths. A third new sheath was formed (darker orange). Scale bar 10µm. See 
also (Auer et al., 2018) 
 
To quantify if the position of the newly formed sheath is indeed at the position where the old 
sheath was I measured the length of the axon stretch between two clearly distinguishable 
landmarks, like collaterals or somata of other neurons and calculated the relative position 
of the sheath before ablation. To avoid influences of the fish growth I used landmarks, like 
somata of other neurons or axon collaterals, to determine the sheath position on the axon. 
To precisely determine the sheath position, independent of sheath length, I always used the 
position of the center of the sheath.  
When the new sheath was formed I did the same measurements using the same landmarks 
for the respective neurons. In order to obtain the difference in sheath position I calculated 
the difference of the relative positions before and after ablation. To compare the relative 
changes in sheath positioning, I measured the relative positions of myelin sheaths without 
ablation with the same time difference between the two measurements.  
I found that there was no difference in the changes of sheath position between control 
myelin sheaths and between the ablation and remyelination group (-2.8% ± 1.6% deviation, 
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n = 5/4 sheaths/axons versus -1.2% ± 1.4% n = 4/2 sheaths/axons in control, p = 0.15, Fig. 
3.21A). I also quantified the length of the ablated and the newly formed sheath. To exclude 
the influence of fish growth, I corrected the sheath length for body growth. The average 
sheath length before ablation was 18.5 ± 5.3 µm and after remyelination, corrected for body 
growth, it was 18.3 ± 5.4 (p = 0.96, n = 4/3 sheaths/animals, Fig. 3.21 B) 
 
Figure 3.19 Quantification of the remyelination of partially myelinated axons 
(A) Quantification of the relative change in position of control sheaths and sheaths before and after ablation. No 
difference could be detected in the sheath positioning between control and ablation. (B) Quantification of the 
length of myelin sheaths before and after ablation. The regenerated myelin sheaths were corrected for body 
growth to exclude differences due to fish growth between de- and remyelination. There was no difference in 
sheath length before and after ablation. See also (Auer et al., 2018) 
 
Together, I could show that myelin sheaths exhibit very stereotypic growth dynamics, with 
a fast sheath growth in the first 3 days that determines length differences and a slow 
elongation phase that compensates for body growth. These growth dynamics are 
independent of neighboring myelin sheaths and timepoint of sheath initiation. Upon 
manipulation, like ablation of neighboring myelin segments, sheaths can deviate from their 
predictive growth and remodel their length. Furthermore, myelination patterns along fully, 
as well as along partially myelinated axons, are regularly restored upon sheath removal, 
indicating axonal regulation of node of Ranvier positioning.   
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3.3 Axonal mechanisms influencing node of Ranvier position 
 
Node of Ranvier positioning is an important factor influencing conduction speed, however, 
how the positioning is regulated is not known yet. My previous results indicate axonal 
influences on node of Ranvier positioning and myelination patterns, as I regularly observed 
reestablishment of myelination patterns along axons. I therefore aimed to further investigate 
how axonal mechanisms might influence node of Ranvier positioning. 
 
3.3.1 Asymmetric lateral sheath growth  
 
During the imaging, I often observed that the feeding process of the myelin sheaths - the 
point of sheath growth initiation (Snaidero and Simons, 2014) -  was not located in the center 
of the sheath, therefore indicating asymmetric lateral extension (Fig 3.22 A, white box). In 
some of the sheaths that I had followed over time, I observed asymmetric growth as well. 
The sheaths seemed to stop growing into one direction while they were still growing into the 
other (Fig 3.22B). To quantify the amount of asymmetrically grown myelin segments I 
analyzed the relative process position of myelin sheaths. To exclude asymmetric growth 
due to neighboring sheaths, I included only myelin sheaths without any neighboring myelin 
segments. I measured sheaths in full transgenic mbp lines to ensure that the sheaths, 
indeed, had no neighboring sheaths. I measured the feeding process position with regard 
to the sheath length. I calculated the relative process position with -1 and 1 being at the end 
of the sheath while 0 marks the middle of the sheath (Fig 3.22 C), and plotted the relative 
process position versus the myelin sheath length. I defined sheaths to be symmetric, when 
their process position did not deviate from the center by more than 5% in each direction. 
About 80% of all sheaths I measured had their process outside of this 10% region around 
the respective center of the sheath (34/42 in 16 animals) and were therefore counted as 
asymmetrically grown. I could not detect any bias towards the sheath length, as long and 
short sheaths were equally asymmetric (r = 0.01 p = 0.942) (Fig 3.22D).  
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Figure 3.22 Asymmetric lateral sheath growth 
(A) Confocal image of a myelinating oligodendrocyte (yellow) in a full transgenic mbp line (green). The white 
box shows an asymmetrically grown myelin sheath. (B) Confocal images of the timeline of the asymmetrically 
grown sheath. At 5dpf it is still symmetric from then on it grows more to the left than to the right, ending up with 
an asymmetrically positioned feeding process. The white arrows point to the ends of the sheath and to the 
feeding process. (C) Scheme of how the relative process position was analyzed. The myelin sheath length was 
set to be from -1 to 1 with 0 being the center of the sheath (D) Quantification of the relative process position. 
Most of the processes are outside of a 10% area (gray area) around the center of the sheath. Scale bar 10µm. 
See also (Auer et al., 2018) 
 
In the previous experiment I only analyzed myelin segments without neighbors, to exclude 
them acting as physical barriers, but other potential physical barriers exist. Some axons 
have collateral sprouts that could act as growth barriers. To see if they can account for the 
asymmetric growth, I assessed the frequency of axon collaterals at nodes of Ranvier. To 
count the number of nodes that had formed due to a collateral, I injected the cntn1b:Nfasca-
EYFP construct together with an axon label, cntn1b:mCherry. Next I screened the fish for 
fully myelinated neurons expressing both markers. I counted the number of nodes that had 
formed at the position of a collateral and the number of nodes that had formed without a 
collateral (Fig 3.23 A). I found that only about a quarter of nodes had formed at positions of 
collaterals (28.5% n=45/158 nodes on 15 axons, Fig. 3.23 B). I never observed a collateral 
on a fully myelinated axon without a node indicating that collaterals are one axonal 
determinant of node position (0/12 nodes, n = 6/6 axons/animals).  
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Figure 3.23 axon collaterals determine node position  
(A) Confocal images of mCherry (cyan) labeled neurons co-expressing Nfasca-EYFP (red). The arrows point to 
the nodes. The upper image shows nodes that are at the position of axon collaterals, the lower image shows 
nodes without axon collaterals. (B) Quantification of nodes with and without collaterals. The majority of nodes 
does not form at positions of collaterals. Scale bar 10µm. See also (Auer et al., 2018) 
 
As only about a quarter of all nodes analyzed had axon collaterals, they cannot alone 
account for the high number (80%) of the observed asymmetric sheath growth. I could show 
that axon collaterals are indeed one axonal determinant of node position, but there must be 
another growth barrier to explain the high number of asymmetrically grown sheaths.  
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3.3.2 Pre-myelination clustering of the nodal protein Neurofascin 
 
The fact that myelin sheaths stop growing and show asymmetric growth even without the 
presence of neighboring sheaths or other physical growth barriers raised the question if 
axonal signals could act as molecular growth barriers.  
As previously mentioned, I observed very different myelination patterns along different types 
of neurons. When I imaged the neurons while there were still unmyelinated stretches 
present, I often observed that Nfasca-EYFP was not homogeneously expressed along the 
unmyelinated parts of the axon. Nfasca-EYFP accumulated and formed clusters along 
unmyelinated axons. It has been shown in vitro that certain nodal proteins like voltage-gated 
sodium channels and AnkyrinG can form functional clusters in unmyelinated axons, if 
treated with oligodendrocyte conditioned medium (Freeman et al., 2015). I investigated if 
Nfasca-EYFP also shows different localization along neuronal types with different 
myelination dynamics.  
Therefore, I co-labelled the respective neuronal types with Nfasca-EYFP and mCherry in 
full transgenic mbp lines. I imaged the neurons from 3dpf onwards, as most of the neurons 
are not fully myelinated by that age, and there are still unmyelinated stretches. I followed 
the neurons for up to 7dpf to assess Nfasca-EYFP localization before and after the axons 
got myelinated.   
Along CoPAs as well as CiDs I observed that Nfasca formed clusters with higher signal 
intensities, but there was always a faint Nfasca signal detectable between clusters, when 
the axons remained unmyelinated. When myelin sheaths were formed Nfasca was fully 
excluded from the ensheathed axon segment (arrows, Fig 24 A).  
 
Along RB axons I also found some ensheathments, but here, unlike the other neurons, the 
Nfasca-EYFP signal was still localized underneath the myelin segment (Fig 3.24 B). 
Whenever I found ensheathments on Nfasca-EYFP labelled RB neurons, the Nfasca signal 
was never excluded from the myelinated parts. Another difference compared to CoPAs and 
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CiDs was that along RB axons Nfasca did not form clusters, it was rather homogeneously 
distributed.  
 
Figure 3.24 Nfasca localization differs along different neuronal types   
(A) Confocal images of a CiD with an ensheathment, Nfasca is excluded from underneath the myelin sheath 
(arrows). Along the unmyelinated parts it shows clustering (asterisk) (B) Confocal images of a RB neuron with 
an ensheathment, Nfasca is not excluded from underneath the myelin segment (arrows) nor does it form clusters 
at the unmyelinated parts. 
 
To better investigate the clustering dynamics of Nfasca, I used the same experimental setup 
as described above, co-labeling of neurons with Nfasca-EYFP and another fluorescent 
protein in full transgenic mbp lines, and took high resolution images of unmyelinated axons 
and partially myelinated axons (Fig 3.25A). To exclude that the clusters are due to axonal 
swellings, I compared the relative fluorescence of Nfasca-EYFP with the localization of the 
cytoplasmic fluorescent protein. I plotted the relative fluorescence intensity of both to assess 
the homogeneity of expression.  
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For CoPA and CiD axons, axons that regularly get myelinated, I found that while the 
cytoplasmic fluorescent protein was expressed homogeneously, Nfasca-EYFP showed 
areas with high fluorescence and parts with very low amounts of fluorescent protein (Fig 
3.25B). At myelinated segments (Fig 3.25 A, yellow bars) there was no Nfasca-EYFP signal. 
There was no correlation between the two different protein localizations, excluding 
accumulation due to physical constraints like swellings. In RB axons Nfasca showed, as 
well as the cytoplasmic labeling, a homogeneous expression along the length of the axon 
(Fig 3.25 C,D).  
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Figure 3.25 Neurofascin clusters along some but not all unmyelinated axons 
(A) Confocal images of a partially unmyelinated CoPA axon labelled with Nfasca-EYFP and tagCFP. The Nfasca 
signal shows clustering while the tagCFP signal is distributed homogeneously. The yellow bars indicate where 
myelin sheaths are formed (B) Graph showing the relative fluorescent intensity of Nfasca-EYFP and tagCFP 
along the axon from (A). Nfasca-EYFP shows a very inhomogeneous distribution while tagCFP is distributed 
homogeneously (C) Confocal image of an unmyelinated RB axon labelled with Nfasca-EYFP and mScarlet. 
Both markers show homogeneous distribution (D) Graph showing the relative fluorescent intensity along the 
axon. Nfasca-EYFP does not show any clustering.  
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I wondered if these clusters are involved in nodal positioning and if they are stable over time 
in an unmylinated axon, and could therefore resemble prenodes, which have been 
described earlier (Kaplan et al., 1997; Freeman et al., 2015).  
To assess the stability of Nfasca-EYFP clusters, I followed unmyelinated axons, labelled 
with Nfasca-EYFP and tagCFP,  over time. I started the imaging at 3dpf. Often there were 
no clusters detectable at these early timepoints (Fig 3.26 3dpf) but at 4dpf Nfasca-EYFP 
clusters started to form. In the beginning they were just slightly brighter than the surrounding 
but with time they became more pronounced. To assess stability, I aligned the images of 
the different timepoints. I found that the clusters were remarkably stable over time in 
neurons that remained unmyelinated. Most of the clusters stayed at the same position 
(moving only due to body growth), and only few clusters appeared or disappeared during 
the imaging (asterisk Fig 3.26).  
 
Figure 3.26 Nfasca clusters are stable over time 
Confocal images of an unmyelinated axon stretch over time from 3 to 7dpf. The left images show the Nfasca-
EYFP channel, the right images the merged images of Nfasca-EYFP (red) with the axon label tagCFP (cyan). 
The Nfasca-EYFP clusters are formed around 4dpf. Most of the clusters are stable (arrows) and only few clusters 
appear or disappear (asterisk).  
 
I found that Nfasca-EYFP shows different dynamics along different neuronal types. Along 
axons that are usually substantially myelinated, like CoPAs and CiDs, Nfasca-EYFP shows 
clustering along unmyelinated parts and it is excluded from myelinated parts of the axon. 
On the other hand, in RB axons that are normally unmyelinated or show only rare, short 
ensheathments, Nfasca-EYFP does not show a clustering behavior, nor is it excluded form 
myelinated parts. 
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3.3.3 Correlation of Neurofascin clusters and node position 
 
The fact that myelin sheaths stop growing even in the absence of neighboring sheaths and 
the presence of Nfasca-EYFP clusters raised the question if Nfasca could act as a molecular 
growth barrier. Another finding supporting the hypothesis of Nfasca acting as a growth 
barrier, and therefore node position determinant, is that I only found clusters in neurons that 
are regularly getting myelinated to a significant proportion. To investigate if sheaths stop 
growing when they reach a Nfasca cluster, I co-labelled axons with Nfasca-EYFP and 
another cytoplasmic marker in full transgenic mbp lines. I used the second cytoplasmic axon 
label to ensure that I analyzed the clusters on one axon and that the myelin sheaths are 
formed on the respective axon. I started imaging at 3dpf, an age where most of the axons 
are not yet fully ensheathed and continued it until the axons were myelinated. I analyzed 
the cluster – node correlation retrospectively. Therefore, I assessed the position of the node 
in the fully myelinated axon and tested if there was a Nfasca cluster at the same position 
before the neuron was myelinated (Fig 3.27). For the analysis of the cluster and node 
position I defined three different cases. I analyzed if there was a pre-myelination cluster at 
the node position, if there was a heminode or if there was no sign of a cluster prior to 
myelination. The heminode was put in a separate category as there is already an 
ensheathment on one side, but the sheath that formed the heminode had stopped growing 
here. To assess if node position and cluster are at the same place, I analyzed the images 
pre and post myelination, and measured if they are at the same position. As fish grow during 
that time, I aligned the images at landmarks to exclude false results due to body growth of 
the fish. I found that for the majority (75%) of the analyzed nodes there was either a cluster 
or a heminode at the same place. Only in 25% percent there was no indication of a cluster 
(Fig 3.27). 
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Figure 3.27 Quantification of Neurofascin cluster and node position 
(A) Confocal images of a partially myelinated neuron that is getting myelinated. The Nfasca clusters that are 
present at 4dpf (white arrows) are at the same position as the nodes at 5dpf (white arrows) when the neuron is 
fully myelinated (B) Confocal images and graphical representation of the three different analysis categories. 
Either there was a cluster at the node position, there was a heminode at the node position of there was no prior 
clustering at the node position. (C) Quantification of the node position. The majority of nodes showed pre-
myelination clustering of Nfasca-EYFP or a heminode at node positon.  
 
When I assessed the cluster – node correlation, I often imaged neurons that did not have 
clusters at 3dpf and at the next day they were fully myelinated. Many axons were myelinated 
very quickly before clusters could emerge which could be due to the Nfasca clustering and 
myelination happen simultaneously. To disentangle these two processes and to prolong the 
time for clusters to be formed I aimed to delay myelination. In another set of experiments, I 
aimed to prevent myelination to investigate if clusters also form in the absence of 
myelination.  
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To ablate the OPCs and therefore prevent myelination, I used a Nitroreductase (NTR) 
mediated cell ablation. Here, NTR reduces the non-toxic prodrug Metronidazole (MTZ) into 
a DNA cross-linking reagent. NTR is expressed in the cells of interest and MTZ is bath 
applied to the fish. Only the cells expressing NTR are ablated while the surrounding tissue 
remains unaffected (Curado et al., 2007).  
I used a transgenic line where NTR fused to tagCFP is expressed in OPCs 
(Tg(olig1:tagCFP-NTR)) to visually confirm the expression of NTR in the cells. I started the 
treatment around 2.5dpf, as the first oligodendrocyte precursor cells appear around 48hpf 
and the first myelin at 60hpf (Brösamle and Halpern, 2002).  
First, I wanted to quantify the reduction of oligodendrocytes with the NTR mediated OPC 
ablation. Therefore, I crossed mbp:nlsEGFP fish with olig1:tagCFP-NTR fish to count the 
number of oligodendrocytes, when OPCs are ablated, during development (Fig 3.28 A). I 
incubated the fish for 24h either with 10mM MTZ in 0.2%DMSO or, the control fish, only 
with 0.2%DMSO in Danieau´s buffer. After the incubation I imaged the fish between 3 and 
9dpf and counted the number of oligodendrocytes in both groups. Similar to the 
oligodendrocyte numbers during development, I imaged the fish around somite 17 but here 
I performed longitudinal studies and imaged the same fish at different ages (Fig 3.28 B).  
At 3dpf there was no difference in cell number between ablated and control fish, but for the 
following timepoints, the oligodendrocyte number in the ablated fish only slightly increased 
until 6dpf. After that no more cells were added.  In the control fish, new cells were constantly 
added, as shown before (cells added from 6-9dpf: 4.3 ± 0.7 vs. 0.2 ± 0.4, p = 0.0286 n=4 
animals). Upon OPC ablation, myelination seems to stop around 6dpf with no new 
oligodendrocytes being generated. The myelination is not fully prevented, but there is a 
significant reduction in oligodendrocytes, at least until 9dpf in the ablated fish (cell number 
at 9dpf 23.5 ± 2.3 vs. 11.1 ± 1.5, p = 0.0286 n=4 animals) (Fig 3.28 C).  
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Fig 3.28 NTR mediated ablation of OPCs reduces the number of oligodendrocytes 
(A) Confocal image of mbp:nlsEGFP (red) x olig1:tagCFP-NTR(cyan) control and MTZ treated animals at 4dpf 
(B) Confocal images of mbp:nlsEGFP from control and MTZ treated animals at 4,6 and 9dpf (C) Quantification 
of oligodendrocyte number per 100µm spinal cord. There is a reduction of EGFP labelled oligodendrocytes in 
the MTZ treated animals.  
 
For the second manipulation, I did not ablate OPCs but aimed to inhibit their differentiation. 
It has been shown before that treating zebrafish with the HDAC inhibitor Trichostatin A 
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(TSA) drastically reduces the number of oligodendrocytes in the spinal cord (Takada and 
Appel, 2010; Early et al., 2018). 
As I wanted to delay myelination by a few days, I first titrated the optimum concentration to 
reduce the number of oligodendrocytes without impacting the development of the fish. I tried 
different concentrations between 5 and 100nM and assed the health appearance of the fish. 
Up to 10nM the fish looked overall healthy and all of them had inflated the swim bladder by 
5dpf. The fish treated with 20nM still appeared healthy but only around 50% inflated their 
swim bladder. I chose to use 15nM TSA to increase the effect of the myelination delay 
without impacting the health of the fish too much. Again, I first quantified the severity of the 
myelination delay. Therefore, I treated mbp:nlsEGFP fish with 15nM TSA in 0.2% DMSO 
for 24-26h starting around 2.5dpf. The control fish were incubated with 0.2% DMSO. I 
imaged the same fish from both groups at 3,4 and 6dpf around somite 17 and counted the 
nlsEGFP labelled cells in the spinal cord (Fig 3.29A).   
I found that there is overall just a slight, not significant, reduction in oligodendrocyte number 
between the control and the TSA treated groups (cell numbers at 6dpf: 22.2 ± 3.7 versus 
20.1 ± 2.1, p = 0.292) (Fig 3.29B). When looking at the cell number of single fish, it appeared 
quite variable, some fish responded to the treatment with a substantial reduction of 
oligodendrocytes, while others had cell numbers similar to controls.  
I also observed in these experiments, that the nlsEGFP signal of the cells in the TSA treated 
animals was dimmer than in the controls. I needed 3-4x the laser power of the controls to 
get similarly bright images in the TSA treated animals (Fig 3.29A).   
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Fig 3.29 Inhibiting OPC differentiation with TSA only slightly reduces the number of oligodendrocytes  
(A) Confocal images of mbp:nlsEGFP fish treated either with 0.2% DMSO (control group) or with 15nM TSA in 
0.2%DMSO. The cells in the TSA treated animals appear dimmer than in the control animals (B) Quantification 
of the oligodendrocyte number in control and treated animals. There is a slight reduction in oligodendrocyte 
number in the TSA treated animals compared to the control, but this reduction is not significant.  
 
 
Although I could not fully prevent the formation of myelin, I used both of the above described 
methods, to prolong the time in which the imaged axons are unmyelinated. To analyze the 
cluster-correlation with the NTR mediated cell ablation I crossed Tg(mbp:tagRFPt-caax) fish 
with Tg(olig1:tagCFP-NTR) fish and injected cntn1b:Nfasca-EYFP as well as 
cntn1b:tagCFP. Although the same fluorescent protein was used to label OPCs and axons, 
they were distinguishable by their morphology. The fish were then treated with MTZ as 
described above.  
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Although the overall delay in myelination was not significant with the TSA treatment, I also 
used this method, as in some fish it substantially decreased the number of 
oligodendrocytes. Here I injected the same constructs, cntn1b:Nfasca-EYFP and 
cntn1b:tagCFP, in Tg(mbp:tagRFPt-caax) fish. I started the treatment around 2.5dpf with 
15nM TSA.  
For both treatments I screened the fish at 3dpf for Nfasca-EYFP and tagCFP positive 
neurons. The neurons were then imaged from 3dpf onwards, until the axon was myelinated. 
I assessed the cluster-node correlation, for each delay method separately, as explained 
before.  I found that, also with a delay or reduction of myelination, the majority of nodes 
were formed at positions where either a Nfasca cluster or a Nfasca heminode had been 
before myelination (Fig 3.30).  
 
Fig 3.30 Quantification of cluster-node correlation with and without myelination delay 
(A) Quantification of the cluster-node correlation with pharmacological treatments to delay myelination (TSA, 
NTR/MTZ). With both of the methods, to delay or reduce myelination, the majority of nodes analyzed had a 
Nfasca cluster or Nfasca heminode at the same position (B) Quantification of all nodes, with and without delay 
of myelination. The majority of nodes had pre-myelination Nfasca clusters or heminodes.  
 
Together, I could show that pre-myelination Nfasca cluster position and post-myelination 
node of Ranvier position highly correlate. Even in fish with pharmacologically induced 
reduction or delay of myelination, this correlation persists.  
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3.3.4 Optogenetic manipulation of myelin sheath length 
 
By correlating Nfasca cluster position with node of Ranvier position, I was able to show that 
cluster position seems to be predictive for node position. As these clusters can also form 
already days before the axon stretch gets myelinated they seem to be intrinsically regulated 
by the axon. It has been shown in culture, that prenodes can be functional in terms of AP 
propagation (Freeman et al., 2015). It could therefore be, that axon intrinsic properties like 
activity regulate the positioning of prenodes or Nfasca clusters. If activity is indeed a 
regulator of cluster position, manipulating activity may induce changes in node position.  
To test this hypothesis, I designed an experimental setup in which I can hyper activate 
single neurons and follow the node positioning. For this experiment I chose to use CoPA 
neurons, for two reasons: they all show fast myelination dynamics and are relatively quickly 
fully myelinated and they are spontaneously very silent, which should maximize possible 
effects due to hyper activation.  
To test if the ChR2 stimulation works in my setup, I tested my settings with embedded fish 
and expressed GCaMP6s to measure Calcium transient. Therefore, I crossed 
Tg(cntn1b:KaltA4) fish with Tg(UAS:GCaMP6s) fish and injected UAS:ChR2-mCherry. I 
then screened for expression of ChR2-mCherry in CoPAs or nearby RB neurons, and 
CoPAs expressing GCaMP6s (Fig 3.31 A). 
The fish was embedded in a glass bottom dish, and the LED was mounted in the lid. I took 
time-lapse movies of GCaMP6s during light stimulation. To see if there are Calcium 
responses upon light stimulation I subtracted the background, as the light from the LED was 
detectable in the GCamp channel, and normalized the curve (Fig 3.31 B).  
I could detect Calcium rises in response to ChR2 activation, confirming that my setup can 
be used for the planned experiment.  
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Figure 3.31 Calcium increases in response to optogenetic stimulation 
(A) Confocal image of a ChR2+ RB neuron and a GCaMP6s+ CoPA (B) Calcium trace of the CoPA labelled in 
(A) during and after optogenetic stimulation. Stimulating the RB cell with blue light elicits a Ca2+ response in the 
CoPA neuron 
 
To test if stimulating and therefore hyper activating the neuron can induce sheath 
remodeling I developed a long-term stimulation setup. 
I used Tg(cntn1b:KaltA4) fish injected with UAS:ChR2-mCherry, cntn1b:tagCFP and 
cntn1b:Nfasca-EYFP. I screened the fish for co-expression of all these markers in CoPA 
neurons. In case I found a CoPA co-expressing Nfasca-EYFP and tagCFP and a nearby 
RB expressing ChR2-mCherry I included these cells as well. I started the imaging at 4dpf 
and followed the axons until 8dpf to know which sheaths have reached their elongation 
phase and are therefore in their predictable growth phase. At 8 and 9dpf the fish were 
stimulated with the optogenetic stimulation protocol. During the stimulation, the fish were 
freely swimming and kept in a small well, to secure equal illumination, with the LED mounted 
into the lid. As it was shown that low frequency stimulation like 1Hz and 8Hz has effects on 
myelination (Piscopo et al., 2018) I chose to use 4Hz as a stimulation frequency. To 
minimize the stress for the fish due to the bright blue light, the stimulation was on for 15s in 
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15min intervals, for 6h per day. I continued to image the axon until 14dpf. For control 
experiments I used fish that did not express ChR2-Cherry and treated them in the same 
way. I then analyzed the sheath length with the Nfasca marker, to assess if node position 
does remodel. To better visualize the effects, I calculated the deviations from the predicted 
growth of each sheath.  
I found that sheaths do remodel upon light stimulation as I saw deviations from their 
predicted growth pattern. I will explain the example #1 in more detail (Fig 3.32 A,A’). Fig. 
3.32 A shows the confocal images of the node marker and the axon marker at timepoints 
before and after stimulation. The images are aligned to the node in the middle to easily see 
the remodeling sheath/node on the left (#6) and the regular growing one on the right (#7). 
Sheath #6 shows shortening after the stimulation and a rapid elongation in the following 
days. Sheath #7 does not show remodeling induced by optogenetic light stimulation.  
The graphs in A’ and B summarize the dynamics of myelin sheaths along axons that express 
ChR2, the graph in C shows the myelin sheath dynamics in a ChR2- fish during and after 
light stimulation. I saw similar remodeling effects in the control animals, likely due to the 
stimulation with bright blue light. When treating the animals, I could observe that during the 
treatment the fish show increased swimming behavior, which also resembles increased 
activity in the neurons. It was not possible to disentangle the ChR2 mediated effects from 
the bright light stimulation effects. Future experiments with ChrimsonR, another light 
sensitive channel that is activated by red light, and also more light sensitive (Klapoetke et 
al., 2014), should circumvent that problem and minimize the side effect caused by the light 
stimulation. 
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Figure 3.32 Activity induced remodeling of myelin sheath length 
(A) Confocal images of a Nfasca-EYFP and tagCFP labeled axon at different timepoints before and after the 
stimulation. The ChR2-mCherry channel is not shown. Two sheaths, #6 and #7, are shown. While #6 shows 
remodeling upon optogenetic stimulation, #7 shows normal growth. (A’-C) Quantification of sheath length 
deviations from predicted values. (A’) Quantification of the axon shown in (A). (B) Quantification of another 
experiment showing smaller effects than the example #1 (C) Quantification of a control fish. Also in the control 
fish, deviations from the predictions could be observed.  
 
Together, I could show that myelin sheaths often show asymmetric growth which cannot be 
explained by physical barriers like neighboring sheaths or axon collaterals, indicating 
molecular growth barriers.  Indeed, when I correlated pre-myelination Nfasca cluster 
position with node of Ranvier position I found that the majority of nodes is formed at a 
position where a cluster had been formed prior to myelination. Furthermore, I collected 
evidence suggesting that node positioning can remodel upon manipulation of neuronal 
activity, although I could detect similar effects in the control, ChR2 negative, fish, which 
could be explained by additional off-target effects caused by the blue light stimulation.  
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4 DISCUSSION 
 
The aim of my thesis was to investigate mechanisms underlying myelin sheath length 
regulation and remodeling. I aimed to investigate how myelin sheath length is established 
during development and how different myelination patterns are formed. I tested for myelin 
sheath plasticity as this is a prerequisite for activity dependent remodeling. Furthermore, I 
investigated pre myelination clustering along axons and how this contributes to node of 
Ranvier positioning.  
Some studies, performed in mouse, reported white matter changes or differences in 
myelination upon manipulations like monocular deprivation or social isolation (Liu et al., 
2012; Makinodan et al., 2012; Etxeberria et al., 2016). However, they could not show if 
existing myelin can actively remodel to adapt to changes in activity. Here, I took advantage 
of the zebrafish as a model where high temporal resolution imaging can be achieved. 
Furthermore, I could show how, during development, different myelin sheath lengths and 
axonal myelination patterns are established and maintained. By a single cell ablation 
paradigm, I could show, for the first time, that established myelin sheaths can plastically 
remodel upon partial demyelination.  
 
4.1 Developmental myelin sheath growth 
 
To study how myelin sheath length is regulated, I approached the question from two 
different perspectives, from the oligodendrocyte point of view and from an axonal point of 
view.  
Myelin sheath length is an important regulator of conduction speed and therefore also 
nervous system function. By adapting myelin sheath length, conduction velocity can be 
modulated and precisely timed (Seidl, 2014; Ford et al., 2015). How myelin sheath length 
is regulated is not fully understood yet, however factors influencing sheath length have been 
identified, e.g. axon diameter (Murray and Blakemore, 1980; Ibrahim et al., 1995) or regional 
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differences (Bechler et al., 2015). It has been shown, that single oligodendrocytes can form 
sheaths of variable length (Murtie et al., 2007; Almeida et al., 2011) and thickness 
(Hildebrand et al., 1993). I analyzed sheath lengths formed by single oligodendrocytes as 
well, and also determined the length spread of myelin sheaths formed. The sheaths formed 
by single cells can span the entire range of lengths measured (Murtie et al., 2007; Almeida 
et al., 2011). As one cell can form sheaths of all observable lengths, this raises the question, 
how an oligodendrocyte achieves to establish sheaths of different lengths. To investigate 
that, I followed myelin segments from their initiation onwards, by which I was able to show 
that all newly formed myelin segments showed very stereotypic growth dynamics, that can 
be separated in three distinct growth phases.  
First growth phase: In the first 8h after differentiation and sheath initiation, all segments 
showed a highly uniformly growth with similar growth rates. This high similarity makes it 
likely, that this growth phase is regulated by oligodendrocyte intrinsic mechanisms without 
extrinsic influences. If there would be extrinsic cues, every sheath would probably 
experience slightly different factors, like axon diameter or different expression of surface 
ligands and hence, every sheath would show different regulation. It has been shown before, 
that on inert fibers, regional oligodendrocyte-intrinsic differences in sheath length can be 
detected (Bechler et al., 2015). As oligodendrocytes readily form myelin in culture on inert 
fibers (Lee et al., 2012a) they might have an oligodendrocyte-intrinsic growth program that 
continues until external regulation starts.  
Second growth phase: The second growth phase starts around 8 hours post initiation (hpi) 
and lasts until 3-4dpi. In this growth phase the sheath length differences are established by 
different growth rates of individual sheaths. As one oligodendrocyte forms sheath with 
different lengths, single sheaths of one cell show different growth rates. The different growth 
rates could be caused by extrinsic signals that influence the rate with which the sheath 
grows. Possible mechanism are local vesicle release, axonal activity or the expression of 
attractive or repulsive cues. During my time-lapse imaging with which I observed the very 
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early sheath growth, the fish were anesthetized with Tricaine which blocks sodium channels 
and therefore reduces neuronal activity (Attili and Hughes, 2014), however I could still 
observe the different growth rates after 8hpi. It is therefore unlikely that the differences are 
solely caused by axonal activity. However, there might still be some remaining activity that 
is not Tricaine sensitive that could cause the differences in growth rate. As it has been 
shown that silencing axons, by blocking synaptic vesicle release, influences sheath length 
on some axon types (Koudelka et al., 2016) and axonal activity might play a role in the early 
stabilization of nascent myelin sheaths (Baraban et al., 2018; Krasnow et al., 2018).  
Time-lapse imaging of sheaths after differentiation with Tetrodotoxin (TTX), to block 
neuronal activity, could give insight if the different growth rates are axonal activity 
dependent. If all sheaths grow with the same dynamics, activity likely plays a role, if they do 
not it would mean that the different sheath growth rates are independent of axonal activity.  
Third growth phase: The third and last growth phase, is a rather passive elongation which 
is again very uniformly among different sheaths. I could show, by correlating sheath length 
in this phase with the fish growth, that sheath length elongates to compensate for body 
growth. As the elongation is again very uniformly and depends on the growth of the fish, I 
was able to show that myelin segment length in the elongation phase can be quite 
accurately predicted by the body length increase of the fish. When the fish grow also the 
axons have to grow in length. As the nodal components are anchored to the cytoskeleton 
they are probably moved with the growth of the axon and the myelin sheath then follows 
and elongates with the same rate. For the PNS it has been shown that elongation of the 
nerve induces myelin elongation (Fernando et al., 2016).  
Myelin sheaths seem to have an intrinsic growth phase that starts with sheath initiation and 
establishes a certain length, then extrinsic signals regulate the growth dynamics and 
determine if a sheath grows fast or slow, which then also determines the length of a sheath. 
The model of an oligodendrocyte intrinsic growth phase followed by adaptive regulation has 
recently been proposed (Bechler et al., 2018). 
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Sheath growth seems to be independent from the surrounding myelin as the presence or 
absence of neighboring sheaths did not alter sheath growth dynamics. One possible 
explanation could be that the length of the sheath and the myelination pattern is already 
defined. This would mean that the sheaths already slow down growth before they have 
reached a potential neighboring sheath, hence the presence of a neighboring sheath does 
not alter the growth. Another possibility could be that a newly formed sheath that meets a 
neighboring sheath pushes it away and moves the node so it can grow. However, this 
seems rather unlikely as I only rarely observed sheaths shrinking and never saw sheaths 
moving along an axon.   
Furthermore, sheath growth seems to be independent of oligodendrocyte densities and of 
the developmental status of the fish as sheath initiated at different timepoints during 
development show the same growth dynamics and sheath lengths, although the cell density 
was increased. As the length of sheaths with two neighboring segments did not differ from 
the length of sheaths with no neighbors, it seems unlikely that sheaths stop growing due to 
physical barriers. There seems to be something else regulating the sheath length that is 
independent from physical barriers. A possible explanation could be that the axon regulates 
the sheath length by different mechanisms, like local vesicle release or expression of 
surface ligands, which could regulate the rate with which sheaths grow and that eventually 
determines the length. 
A potential model of sheath growth dynamics is depicted in Figure 4.1. The first 8h seem to 
be oligodendrocyte intrinsic, as all sheaths show the same growth rate. The second growth 
phase, from 8hpi to 3-4dpi shows very different growth rates that determine the sheath 
length. The different growth rates could be regulated by the axon as sheath formed by one 
cell displayed different growth. The last growth phase is a passive elongation phase in which 
sheath elongate to compensate for body growth.  
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Figure 4.1 Different phases of myelin sheath growth 
In the first 8 hours after initiation all sheaths grow with similar dynamics and have roughly the same length. This 
phase is likely regulated by oligodendrocyte intrinsic mechanisms. After that, until 3-4dpi the sheaths exhibit 
different growth rates and the length differences between the individual sheaths are established, likely regulated 
by axonal mechanisms. From 3-4dpi onwards the sheath show only elongation to compensate for body growth. 
The growth rates are again very similar.  
 
The previous experiments suggested that axonal influences might regulate sheath length 
by altering sheath growth rate. The next question I approached was, if axonal influences 
play a role, how are sheaths lengths along one axon distributed?  
I analyzed sheath lengths along different axons and found that it is quite variable, however, 
there are some axons that displayed overall shorter sheaths, while other axons had overall 
longer ones. This finding also supports the hypothesis of axonal control of sheath lengths, 
however there must be some more local influences that regulate the exact sheath length. 
Furthermore, I could not detect any correlation with the diameter, indicating as well a more 
local regulation for every individual sheath, rather than only physical mechanisms like 
diameter. But one also has to keep in mind that the diameter was measured with light 
microscopy and therefore small differences might have been underestimated.  
The arrangement of long and short myelin segments along an axon resulted in the formation 
of specific myelination patterns. When I followed these patterns over time, I could show that 
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once a pattern is established, it is remarkably stable over time, and that they are a unique 
feature of every individual axon. Myelination patterns along the same type of axon greatly 
differed, likely due to each axon establishing the pattern for it to function best, depending 
on the length and the targets of the axon.  
Axons cannot only show full myelination, but also partial myelination patterns were detected 
in cortical layers in the mouse (Tomassy et al., 2014; Micheva et al., 2016). I could show 
that also in zebrafish partial myelination patterns exits and by following them over time, I 
was able to show that they can be maintained for longer periods of time. Similarly, also in 
mouse cortex partial myelination patterns were observed to be maintained for some time 
(Hughes et al., 2018) but also ongoing myelination of partially myelinated axons was 
observed (Hill et al., 2018). Sheaths on these axons are not longer than sheaths on fully 
myelinated axons, although there would be space for them to grow longer. Hence, 
something must stop them from growing.  Theoretically, it could be a general growth stop 
regulated intrinsically by the oligodendrocyte or local axonal signals defining permissive and 
non-permissive areas, resulting in a growth stop. If there is a general growth stop in 
oligodendrocytes that determines the length one could follow sheath growth of 
oligodendrocytes where Pten is knocked out, which leads to elevated PIP3 levels which 
was shown to induce hypermyelination (Goebbels et al., 2012). If the sheath lengths or 
growth dynamics are not altered this argues for a local regulation of sheath growth stop 
instead of a general growth stop of the oligodendrocyte.  
It was hypothesized, that discontinuous myelination patterns might be involved in higher 
brain functions (Tomassy et al., 2014). However, single, short ensheathments might not 
have a strong influence on AP conduction speed, but, due to local clustering and higher 
densities of voltage gated channels at the heminodes, they might have an influence on the 
shape of action potentials (Günay et al., 2008; Zhang et al., 2018). The action potential 
shape, depending if it is wider or more narrow, changes the duration of the depolarization, 
which might have implications for circuit function as it increases or decreases the chances 
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of simultaneous arrival of several inputs. If single ensheathments do indeed alter action 
potential shape could be tested with electrophysiology or computational modeling. Another 
function of the sparse ensheathment could be to provide local metabolic support, however, 
this would imply that there is a static, locally increased need for energy. 
As mentioned before, when I assessed sheath length along single axons I found that some 
had overall shorter, other overall longer myelin sheaths. This already indicates an axonal 
influence on myelin sheath length. However, one factor that is similar among the same type 
of neuron is the myelination coverage. Especially for CoPAs and RB it was very stereotypic, 
for the CiDs it was rather divers, but literature suggests also that there are more CiD 
subtypes (Menelaou et al., 2019) that exhibit different functions (Pujala and Koyama, 2019) 
and they could exhibit different myelination dynamics.  
I also detected a correlation between diameter and myelination, as it has been reported 
before (Murray and Blakemore, 1980); Almeida et al., 2011). But as RBs have an overall 
smaller diameter than CoPAs, the myelination differences between these two could 
therefore also be due to them being different neurons instead of just diameter dependent. 
For the CiD there is a clear correlation between diameter and myelination.  
I also assessed spontaneous axonal activity, as it has been shown before that activity can 
influence myelination and OPC differentiation (Gibson et al., 2014; Mensch et al., 2015; 
Koudelka et al., 2016; Mitew et al., 2018). CoPAs showed almost no spontaneous activity, 
likely be explained by them being integrated in sensory circuits. The CiDs are involved in 
motor output, and they might be integrated in central pattern generators (CPG) that produce 
regular patterns of activity (Kimura et al., 2006). Also here, I observed a very diverse pattern 
for the CiDs, namely that some were highly active while others showed only few Ca2+ 
transients, which can likely also be explained by the existence of different subtypes of CiDs. 
RB showed some activity, roughly 50% of the analyzed ones showed Ca2+ transients, but 
fewer transients compared to CiDs.  
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I could not detect any correlation between spontaneous activity and the amount of 
ensheathment along axons of the same type. The most ensheathed type (CoPAs) were the 
least active ones. Consistently, it has been shown that blocking vesicle release in CoPAs 
did not change myelination (Koudelka et al., 2016), arguing for an activity independent 
regulation of the amount of myelin formed along these axons. As CoPAs are involved in 
escape responses (Ritter et al., 2001) that have to function from very early onwards the fast 
myelination of these axons might be regulated independent of activity to secure a fast 
myelination and functioning of these neurons.  
For CiDs I observed high variabilities for both parameters, but as the data was acquired in 
two independent experiments I could not assess if along CiDs the amount of ensheathment 
correlates with spontaneous activity. To investigate if myelination along different types of 
CiDs is activity dependent, and if the activity and myelination status correlates with the 
different types of CiDs, one could do the experiment of myelin coverage and activity in the 
same animal and assess both parameters for each neuron.  
Together, I was able to describe the growth dynamics of newly generated myelin sheaths 
with the three different growth phases. Furthermore, I assessed how different myelination 
patterns are established and maintained.  
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4.2 Manipulation of myelin sheath length 
 
I aimed to test if established sheaths are able to reinitiate growth again, also long after 
sheath initiation when they are in their passive elongation phase, as this could be an 
important regulator to adjust conduction properties. In order to test the ability of sheaths to 
grow after their active growth phase, I established a laser ablation method, with which I was 
able to precisely ablate single oligodendrocytes and their respective sheaths. I used two 
different experimental setups, ablation of single sheaths along fully myelinated axons and 
demyelination of partially myelinated axons.  
With the first paradigm I wanted to test if the neighboring sheaths are able to remodel and 
if sheath length is plastic and can adapt after manipulations.  
I hypothesized two possible remyelination scenarios, either the neighbors reinitiate sheath 
growth and invade the demyelinated axon or a new sheath is formed to remyelinate it. The 
first would imply that myelin sheaths are indeed able to remodel and that they sense that 
the neighboring sheath was ablated, the latter would mean that sheaths are not able to 
remodel their length upon local demyelination. When I did the experiments, I observed that 
often a combination of these two events took place. First the neighbors reinitiated fast 
sheath growth, followed by the formation of a new myelin sheath. I could show, for the first 
time, that existing myelin sheaths can remodel upon manipulation like ablation of 
neighboring sheaths. It has now also been shown that in the mouse cortex, myelin sheaths 
can show length changes during development (Hill et al., 2018; Hughes et al., 2018). The 
potential ability of existing myelin sheaths to remodel and change in length holds great 
potential as a mechanism to adaptively modulate conduction properties. As the invasion of 
the neighboring sheaths occurred before the formation of a new sheath it could be a faster 
reaction to changes than oligodendrogenesis.  
In some cases, the neighboring sheaths did not reinitiate growth again, but the nodes stayed 
at their initial position. As I sometimes observed axon collaterals, they could explain why 
some sheaths did not show remodeling due to the collaterals acting as physical growth 
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barriers. To test if the collaterals account for the cases in which I did not observe remodeling 
I compared their frequency. In 23.5% (4/17) of the cases I did not observe remodeling and 
in 28.5% of nodes I observed collaterals, therefore it is likely that the collaterals prevented 
sheath remodeling in these four cases.  
But why do the myelin sheaths reinitiate growth again to cover the demyelinated area? 
During development sheaths also stop growing without meeting a neighboring sheath. A 
possible explanation could be, that due to the ablation permissive axon is exposed and 
diffusion of nodal proteins, potentially the removal of molecular stop signals, may allow for 
further growth of the myelin sheath. I did not analyze the dynamics of nodal markers after 
demyelination. Some could stay anchored at the cytoskeleton, and therefore mark the 
position of the ablated sheath, while others could diffuse to allow sheath growth. It would 
be interesting, in future experiments to see how different nodal proteins react to 
demyelination and if they are actively involved in myelin remodeling.  
Upon ablation of an oligodendrocyte and following demyelination of the respective axons, 
a new myelin sheath is formed. There are two possible sources, where the myelin sheaths 
could come from. The first is, that an oligodendrocyte precursor cell differentiated as a 
response to the cell ablation of an oligodendrocyte. The other option is, that a mature 
oligodendrocyte extended a process and remyelinated the axon. During development, 
differentiating oligodendrocytes only have a 5h time-window to generate new sheaths 
(Czopka et al., 2013), however, recent evidences suggests that in a demyelinated 
environment mature oligodendrocytes are capable of extending processes and forming new 
myelin sheaths (Duncan et al., 2018; Jäkel et al., 2019; Yeung et al., 2019).  
EM reconstructions from demyelinated lesions in cats or rhesus monkeys showed 
oligodendrocytes that were connected to mature thick sheaths as well as thin remyelinated 
ones, leading to the possibility that mature oligodendrocytes can, under certain 
circumstances participate in remyelination. The oligodendrocyte participating in 
remyelination are probably cells that had lost some sheaths by the demyelination (Duncan 
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et al., 2018). Yeung et al. could show by birth dating of oligodendrocytes in MS lesions, that 
in shadow plaques no new oligodendrocytes were formed although there was remyelination, 
arguing that the myelin came from mature oligodendrocytes, however, cells do not 
necessarily have to divide before differentiation, they could have been already at the lesion 
site as pre-oligodendrocytes and thereby not detected as newly myelinating 
oligodendrocytes (Yeung et al., 2019). Another study, comparing human healthy and MS 
tissue by single nucleus RNA sequencing, showed enhanced myelin gene expression in 
mature oligodendrocytes, arguing as well for their participation in remyelination in MS 
lesions (Jäkel et al., 2019). 
There is accumulating evidence, that mature oligodendrocyte can, under certain 
circumstances participate in remyelination. However, in my experiments the damage and 
inflammation are minimal and most likely to subtle to induce the regrowth of a myelinating 
process of a mature oligodendrocytes. In my experiments, the newly formed myelin most 
likely comes from a newly differentiated oligodendrocyte.  
Interestingly, I often observed reestablishment of the pre-ablation pattern. One possible 
mechanism of how this could be achieved is, that parts of the cytoskeleton, where the nodal 
proteins are anchored, remains at the initial position and guide the sheaths after 
remyelination to reestablish the functional pattern. As myelin segment length influences 
conduction speed this could be an important mechanism to re-establish the initial 
conduction properties.  
During developmental growth, the myelin sheaths are getting compacted and cytoplasmic 
channels are closed (Snaidero et al., 2014). To reinitiate sheath growth cytoplasmic 
channels would need to be opened to allow transport of myelin components to the growing 
regions. It has been shown that upon activation of P(3,4,5)P3 in oligodendrocytes, 
cytoplasmic channels can reopen and myelin sheath growth, here in form of increases in 
thickness, was observed (Snaidero et al., 2014). Opening of cytoplasmic channels could 
also be the way of how sheath growth reinitiates upon oligodendrocyte ablation. Local 
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axonal signaling, due to the demyelination, could induce the opening of cytoplasmic 
channels to allow for fast sheath growth. This could represent a mechanism of how the axon 
achieves fast remyelination of the demyelinated axon, by local axon to oligodendrocyte 
communication, to restore fast AP conduction properties.  
With the second ablation paradigm, I demyelinated partially myelinated axons, to see if also 
here the myelination patterns are reestablished again. By labelling the axon as well in these 
experiments, I secured that newly formed sheaths are indeed along the same axon and to 
assess if physical growth barriers like axon collaterals exist. After demyelination I observed, 
that the ablated myelin sheaths were replaced by new sheaths at similar positions and with 
a similar length. Possible explanations for this could be that there are, similar to the ablation 
along fully myelinated axons, nodal molecules that remain at their initial position due to 
anchorage at the cytoskeleton. It could also well be that extracellular matrix remains at its 
initial position and guides the newly formed sheath to remyelinate the exact same part of 
the axon. Another factor could be that the axon has permissive and non-permissive regions 
for myelination. Upon ablation, the permissive stretch of axon is exposed and is 
remyelinated again, while the non-permissive regions stay unmyelinated. A mechanism 
where axons define permissive and non-permissive areas has been recently published. 
Here axons defined myelinated and unmyelinated regions by expression of Galectin-4 
(Díez-Revuelta et al., 2017).  
As the slow elongation phase is due to body growth it is predictable and there is no active 
growth of sheath length after this time, this could either mean that the oligodendrocyte has 
shut down its growth program or that the sheaths stopped growing due to having reached 
their final position. As ablation of neighboring sheaths initiates a fast growth again it seems 
likely that the growth during development ceases due to local regulation at the axon-glia 
interface instead of a general stop of sheath growth by the oligodendrocyte.  
It remains unclear how the remodeling of myelin sheaths upon ablation is mechanistically 
regulated. I hypothesized two mechanisms how this could be achieved. (1) axon to 
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oligodendrocyte communication or (2) axon intrinsic positioning of nodes with the myelin 
sheath passively following (Fig 4.2).  
In the first option, the axon would have to locally signal to the neighboring sheaths to grow. 
Once the new sheath is formed it becomes more complicated as the new sheath is growing 
while the neighboring sheath is shrinking again. This could only be achieved by very local 
communication. Recent studies suggest that local calcium signals in young myelin sheaths, 
partially induced by axonal activity, regulate if the sheaths grow, stop or shrink (Baraban et 
al., 2018; Krasnow et al., 2018). A similar mechanism could come to play here as well; 
however, it remains difficult to envision how neighboring sheaths can display opposite 
dynamics.  
The other option, axon intrinsic control of node positioning seems more intuitive and easier 
to implement, as the axon could move the node and the sheaths would just passively follow. 
Additionally, complex myelination patterns, as they have been observed in the gerbil 
auditory system, with sheaths getting shorter closer to the synapse (Ford et al., 2015), could 
easily be established by axon intrinsic node positioning.  
However, these two mechanisms are not mutually exclusive and the truth could be a 
combination of both.   
 
Figure 4.2 Possible mechanism of how myelin sheath remodeling is mechanistically regulated 
(A) Axon to oligodendrocyte communication. Local signals regulate that sheaths are growing or shrinking (B) 
Axon intrinsic control of node position. The axon intrinsically regulates node positioning and the myelin sheaths 
passively follow 
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4.3 Axonal control of myelin sheath length 
 
In the first two sections of my thesis I collected evidence, that sheath length and the resulting 
myelination pattern might be determined by extrinsic cues from the axon. This regulation 
could be managed by anchoring of nodal, but also paranodal proteins, to the cytoskeleton, 
which is supported by the experiments where I saw re-establishment of pre-ablation 
patterns.  
While imaging, I often observed asymmetric sheath growth, where sheaths were extending 
into one direction but not in the other, that could not be explained by the presence of 
physical growth barriers like neighboring sheaths or axon collaterals. As the sheaths where 
only growing into one direction it seemed as there would be an ‘invisible’ barrier, which 
could be, instead of a physical barrier, a molecular one. 
To investigate if nodal proteins could act as a molecular growth barrier, I used the 
transmembrane nodal protein Nfasca. Neurofascin 186, the homologous protein in 
mammals, was shown be involved in node formation, where it is suggested to cluster due 
to ECM at the node of Ranvier (Susuki et al., 2013).   
I observed specific localization dynamics of Nfasca along neurons that were supposed to 
be myelinated (CoPAs and CiDs were identified to get substantial amount of myelination in 
the first week of zebrafish development). First of all, Nfasca is a suitable marker to label 
unmyelinated axon stretches in these neurons, as it reliably localized only to unmyelinated 
parts and was entirely removed from ensheathed axon segments. Even the formation of 
very young ensheathments led to the removal of Nfasca from the ensheathed part, securing 
that the presence of Nfasca signal correlates with the absence of myelin. Second, during 
development, when parts of the axon stayed unmyelinated, Nfasca clustered along these 
stretches.  
The other localization dynamics I observed, were along RB neurons. RB neurons are rarely 
ensheathed and if they are, then only by short, often transient myelin segments. Here, unlike 
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the myelinated axons, when one of the rare ensheathments was formed, Nfasca was 
surprisingly not excluded from underneath the myelin segment. Along RB axons, although 
not myelinated, Nfasca did also not form clusters, but it stayed homogeneously distributed. 
Different localization dynamics of Nfasca, clustering along some but not all axons, might be 
explained by axon intrinsic differences. First, RB neurons are normally not myelinated, so 
there is no need to already cluster nodal proteins as there are no nodes to be formed. This 
would imply that these dynamics should be seen along all unmyelinated neurons. In my 
thesis, I only focused on RB neurons as largely unmyelinated neurons, but it would be 
interesting to investigate the differences of Nfasca dynamics along other unmyelinated 
axons. If there is no clustering this would imply that Nfasca clustering plays a role during 
myelination and therefore support the hypothesis of axonal mechanisms regulating 
myelination.  
Another difference is, that RB neurons are special, as they only occur in fish and amphibians 
(Lamborghini, 1987; Williams et al., 2000), and during development they are replaced by 
DRG neurons. Some studies suggested that RB neurons die early in zebrafish during 
development (Williams et al., 2000; Svoboda et al., 2001), but we and others (Knafo and 
Wyart, 2018) observed RB neurons also at later stages. The different dynamics could 
therefore also be explained by the different evolutionary origin. 
At first, around 3dpf, Nfasca was homogeneously distributed, also in CoPA and CiD axons, 
then clusters did emerge and they became more pronounced when the neuron stayed 
unmyelinated. I followed these clusters over time and found them to be remarkably stable. 
They only move due to body growth. Very rarely I observed new clusters being formed or 
existing clusters disappearing. The high stability, as well as the moving due to body growth, 
might be explained by cytoskeletal anchoring of these clusters, similar to nodes. Clustering 
of nodal proteins, like sodium channels or AnkyrinG, have been shown before (Kaplan et 
al., 1997); (Freeman et al., 2015). In vitro, the cluster, or prenode formation depended on 
AnkyrinG, whereas Neurofascin186 was dispensable (Freeman et al., 2015). It could well 
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be that this is also the case for the Nfasca clusters I observed in vivo. However, as 
Neurofascin has an AnkyrinG binding motif, the Nfasca clustering could also be due to prior 
AnkyrinG clustering. 
I hypothesized that these Neurofascin clusters could serve as growth barriers during 
developmental sheath growth, explaining the high probability of asymmetric growth. To test 
if the clusters serve as growth barriers and therefore determine node position, I imaged 
unmyelinated axons with clusters and followed them until they got myelinated. I correlated 
the node position with the pre-myelination cluster position and found that the majority of 
nodes were formed at position with prior clusters, indicating that sheaths had stopped 
growing once they reached the clusters. As mentioned before, a mechanism where the 
axon intrinsically defines the node position could explain how specific myelination patterns 
along axons (Ford et al., 2015) are implemented. There are some known factors by which 
axons regulate regions that are to be myelinated or to prevent myelination. JAM2 was 
shown to prevent somatodendritic myelination (Redmond et al., 2016), and it was has been 
shown that Galectin-4 expression in neurons labels unmyelinated stretches and prevents 
their myelination (Díez-Revuelta et al., 2017). 
When I followed the axon in these experiments I did not always see clusters forming. Often 
the axons did show homogeneous distribution and at the next imaging timepoint they were 
fully myelinated. The clustering and myelination could happen almost simultaneously, 
making it hard to disentangle them and assess which of them happens first. To circumvent 
this problem, I aimed to inhibit myelination to investigate if clusters still form in the absence 
of myelin. When doing so, by the ablation of NTR expressing OPCs with MTZ, I still 
observed a substantial amount of myelin formed in the beginning. The NTR was expressed 
under control of olig1 promoter elements and when these cells emerge it takes some time 
for the NTR to be expressed and to function. The formed myelin might therefore be 
explained by the OPCs that had already differentiated before the NTR could transform MTZ 
into the DNA crosslinking agent. Instead of a prevention, myelination was delayed. 
109 
 
Nevertheless, it prolonged the time in which the neuron was unmyelinated, and I could see 
clusters forming. When the axons were getting myelinated and nodes formed, I assessed 
the cluster node correlation as well and found similar results. I could see that the majority 
of nodes had formed at positions with pre-myelination clusters, suggesting that clusters do 
emerge before myelination and are predictive for node positioning.  
If Neurofascin clustering plays an important role in defining node position, it would be 
interesting to investigate what happens when Nfasca is knocked out. If it has a role in 
determining node position and stops sheath from growing, in Nfasca KO more sheaths 
should grow symmetrically and they should also be longer. 
Based on the experimental evidence I, hypothesize that the axon determines node of 
Ranvier position, however, the exact pattern might be refined by the communication of 
myelin sheaths/oligodendrocytes and the ensheathed axon. The phenomenon of pre-
patterning with subsequent refinement of the pattern has already been suggested in other 
systems, like nicotinic acetylcholine receptor clustering at the motor end plate (Kummer et 
al., 2006).  
If the axon determines the node position, how should the sheaths then know how fast they 
should grow, as the growth rates determine sheath length differences in the second growth 
phase? One possible explanation could be, that there are gradients of either permissive or 
repulsive cues that regulate growth rates locally at the axon-glia interface.  
In the last experiment of my thesis I aimed to test for axon intrinsic control of sheath length. 
To investigate that, I wanted to change an axon intrinsic feature and test for node of Ranvier 
remodeling. I therefore manipulated activity by optogenetics and hyperactivated a 
spontaneously very silent neuron and followed node position over time. With pre-stimulation 
imaging I secured that the sheaths have reached their elongation phase. Upon the 
optogenetic stimulation I observed that some nodes, and therefore also sheath lengths, 
remodeled and changed their relative position. Some sheaths showed deviations from their 
predicted length, indicating activity dependent remodeling. However, I could observe similar 
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effects in my control experiments, where I did not express Channelrhodopsin. This ‘off-
target’ effect might be explained by the stimulation of the fish with bright blue light. I 
observed increased swimming in the light stimulated fish, which could also indicate an 
overall increased neuronal activity, making it impossible to disentangle the 
Channelrhodopsin mediated effect from the general light stimulation effect. Furthermore, it 
has recently been shown that stimulation with blue light, in contrast to green or red light, 
alters neuronal gene expression (Tyssowski and Gray, 2019), adding another layer of 
uncontrolled effects. Hence, we decided, for our future experiments, to switch from 
Channelrhodopsin to the light activated channel ChrimsonR (Klapoetke et al., 2014). 
ChrimsonR is activated by red light, and therefore not altering gene expression (Tyssowski 
and Gray, 2019), and it is more light sensitive than Channelrhodopsin, which should reduce 
the ‘off-target’ effect by the light stimulation.  
Nevertheless, activity induced remodeling could also be caused by axon to oligodendrocyte 
communication. Local vesicle release or other mechanisms, as a consequence of increased 
activity, could induce sheath remodeling. One way of testing for that, excluding any glial 
influence, would be to test if pre-myelination clusters of Nfasca can remodel. As mentioned 
before, without interference these clusters are remarkably stable, probably due to 
anchorage to the cytoskeleton. Activity dependent changes in cluster position would 
therefore imply that the axon intrinsically regulates where these clusters are deposited along 
the axon and, as the clusters are determinants for nodes, also where nodes of Ranvier will 
be.  
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4.4 Hypothetical model of myelin sheath length regulation 
 
Based on the accumulating evidence, I have formulated a hypothetical model of how myelin 
sheath length and node of Ranvier positioning are axon intrinsically regulated. During early 
development clusters of Neurofascin formed along unmyelinated axons, and when these 
axons were getting myelinated, node position correlated with the prior cluster position in 
most of the cases. This clustering could occur due to axon intrinsic regulation but it could 
also be induced by other cells like OPCs. In vitro, nodal proteins only cluster upon treatment 
with oligodendrocyte conditioned medium (Freeman et al., 2015) it is therefore likely, that a 
secreted factor induces the cluster formation. Similarly, an oligodendrocyte secreted factor 
could induce the clustering. As I was not able to fully prevent the formation of myelin by the 
ablation of OPCs I am not able to test if clusters would form in vivo in the absence of 
oligodendrocytes and OPCs.  
As I could not prevent myelination with the HDAC inhibitor another strategy could be to use 
a znf16l mutant fish that shows substantial delay of myelination (Sidik and Talbot, 2015). In 
these mutants the number of myelinated axons is reduced by a factor of 10 at 5dpf which 
is around the timepoint where I did my cluster experiment. Hence, it should be possible to 
observe in these mutants how the clustering dynamics of Nfasca are affected or altered in 
the absence or substantial reduction of myelination. In the PNS it has been shown that the 
lack of Schwann cells results in a reduction of clusters of sodium channels and that they 
show abnormal morphology in terms of width and symmetry (Voas et al., 2009).  In culture, 
on the other hand, similar to the CNS (Kaplan et al., 1997), the absence of Schwann cells 
prevents cluster formation in dorsal root ganglion neuron cultures (Eshed et al., 2005). In 
vivo clustering might therefore use different or additional mechanisms compared to 
clustering of nodal proteins in culture. It could therefore well be that in the zebrafish CNS 
nodal proteins cluster in the absence of myelin. To conclude, already the pre-myelination 
clustering of nodal proteins, like sodium channels or Nfasca, in vivo might depend on 
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several independent mechanisms that are partially axon intrinsic but also depend on glial 
cells similar to the node assembly mechanisms (Susuki et al., 2013).   
If Nfasca clusters act as growth barriers, and myelin sheaths are formed at random positions 
along the axon, this would also explain the asymmetric growth. Asymmetric growth, as well 
as growth rate differences, could be regulated by gradients of permissive or repulsive cues. 
Due to the gradient sheaths would display faster or slower growth rates, that eventually 
determine the sheath length.  On the other hand, the different growth rates could also be 
regulated by other mechanisms like local vesicle release. Furthermore, Neurofascin does 
not need to be the master regulator of these processes, it could well be that it´s localization 
is regulated by other nodal proteins or yet unknown factors. Nevertheless, axonal intrinsic 
control of sheath length seems to be highly involved in establishing and maintaining axonal 
myelination patterns.  
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Figure 4.3 Hypothetical model of sheath length regulation by axonal mechanisms along fully and 
partially myelinated axons 
Hypothetical model of how different myelination patterns are established. In the beginning Neurofascin is 
homogeneously expressed along the axon. During maturation Neurofascin starts forming clusters. Myelin 
sheaths are formed. As they are formed at random positions along the axon they exhibit asymmetric growth. 
The sheaths exhibit different growth speeds. After 3-4dpi growth stops even in the absence of physical barriers. 
Results from my experiments are indicated in the labeling.  
 
Taken together, I could show how different myelin sheath lengths are established and 
describe their growth dynamics. Furthermore, I was able to show for the first time, that 
normally very stable myelin sheaths are able to remodel upon manipulation.  
I could also accumulate evidence that myelin segment length and node of Ranvier 
positioning might be axon intrinsically regulated, upon which I formulated a hypothetical 
model (Fig 4.3) of how this could be achieved and how it fits with my experimental results.   
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